<!DOCTYPE html>
<!-- saved from url=(0053)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/ -->
<html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><link rel="stylesheet" type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/jig.min.css">
    
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.04fe9e55f2b2.css" type="text/css">
  
  <link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.aafaa535cb7f.css" type="text/css"><link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.ca6dfa7b90b5.css" type="text/css"><link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/font-awesome.min.css">
  
<link type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/base.a2ef7ca69e4b20dff539.css" rel="stylesheet">


    <link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/stixfonts.css" type="text/css"><link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/pmcrefs1.min.css" type="text/css"><link rel="stylesheet" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/ncbi_web.min.css" type="text/css"><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/article.3c5d12ff2e4beea20136.css" rel="stylesheet">
    <link type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/cite-box.css" rel="stylesheet">


    <title>Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico">
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png">

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png">

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend">

<meta name="ncbi_db" content="pmc">

<meta name="ncbi_phid" content="D0BDDA81ACC17A750000611160544210.1.m_2">


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article">

<meta name="ncbi_op" content="retrieved">

<meta name="ncbi_app_version" content="1.6.0.post2+24fead6">

<meta name="ncbi_domain" content="ccon">

<meta name="ncbi_type" content="fulltext">

<meta name="ncbi_pcid" content="/articles/PMC8581784/">


    


    <script type="text/javascript" async="" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/js"></script><script async="" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/gtm.js" id="pingerInjectedGTM"></script><script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Cancer Control : Journal of the Moffitt Cancer Center"><meta name="citation_title" content="Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis"><meta name="citation_author" content="Avani M. Kolla"><meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Gerardo A. Vitiello"><meta name="citation_author_institution" content="Department of Surgery, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Erica B. Friedman"><meta name="citation_author_institution" content="Department of Surgery, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="James Sun"><meta name="citation_author_institution" content="Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA"><meta name="citation_author" content="Aishwarya Potdar"><meta name="citation_author_institution" content="Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA"><meta name="citation_author_institution" content="Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA"><meta name="citation_author" content="Hala Daou"><meta name="citation_author_institution" content="Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA"><meta name="citation_author_institution" content="Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA"><meta name="citation_author" content="Norma E. Farrow"><meta name="citation_author_institution" content="Department of Surgery, Duke University, Durham, NC, USA"><meta name="citation_author" content="Clara R. Farley"><meta name="citation_author_institution" content="Department of Surgery, Emory University, Atlanta, GA, USA"><meta name="citation_author" content="John T. Vetto"><meta name="citation_author_institution" content="Department of Surgery, Oregon Health &amp; Science University, Portland, OR, USA"><meta name="citation_author" content="Dale Han"><meta name="citation_author_institution" content="Department of Surgery, Oregon Health &amp; Science University, Portland, OR, USA"><meta name="citation_author" content="Marvi Tariq"><meta name="citation_author_institution" content="Department of Surgery, Emory University, Atlanta, GA, USA"><meta name="citation_author" content="Georgia M Beasley"><meta name="citation_author_institution" content="Department of Surgery, Duke University, Durham, NC, USA"><meta name="citation_author" content="Carlo M. Contreras"><meta name="citation_author_institution" content="Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA"><meta name="citation_author" content="Michael Lowe"><meta name="citation_author_institution" content="Department of Surgery, Emory University, Atlanta, GA, USA"><meta name="citation_author" content="Jonathan S. Zager"><meta name="citation_author_institution" content="Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA"><meta name="citation_author_institution" content="Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA"><meta name="citation_author" content="Iman Osman"><meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Russell S. Berman"><meta name="citation_author_institution" content="Department of Surgery, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Tracey N. Liebman"><meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Jennifer A. Stein"><meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA"><meta name="citation_author" content="Ann Y. Lee"><meta name="citation_author_institution" content="Department of Surgery, NYU Langone Health, New York, NY, USA"><meta name="citation_publication_date" content="Jan-Dec 2021"><meta name="citation_volume" content="28"><meta name="citation_doi" content="10.1177/10732748211053567"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8581784/?report=abstract"><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8581784/"><meta name="citation_pmid" content="34752172"><meta name="DC.Title" content="Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="SAGE Publications"><meta name="DC.Contributor" content="Avani M. Kolla"><meta name="DC.Contributor" content="Gerardo A. Vitiello"><meta name="DC.Contributor" content="Erica B. Friedman"><meta name="DC.Contributor" content="James Sun"><meta name="DC.Contributor" content="Aishwarya Potdar"><meta name="DC.Contributor" content="Hala Daou"><meta name="DC.Contributor" content="Norma E. Farrow"><meta name="DC.Contributor" content="Clara R. Farley"><meta name="DC.Contributor" content="John T. Vetto"><meta name="DC.Contributor" content="Dale Han"><meta name="DC.Contributor" content="Marvi Tariq"><meta name="DC.Contributor" content="Georgia M Beasley"><meta name="DC.Contributor" content="Carlo M. Contreras"><meta name="DC.Contributor" content="Michael Lowe"><meta name="DC.Contributor" content="Jonathan S. Zager"><meta name="DC.Contributor" content="Iman Osman"><meta name="DC.Contributor" content="Russell S. Berman"><meta name="DC.Contributor" content="Tracey N. Liebman"><meta name="DC.Contributor" content="Jennifer A. Stein"><meta name="DC.Contributor" content="Ann Y. Lee"><meta name="DC.Date" content="Jan-Dec 2021"><meta name="DC.Identifier" content="10.1177/10732748211053567"><meta name="DC.Language" content="en"><meta property="og:title" content="Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis"><meta property="og:type" content="article"><meta property="og:description" content="Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care.To analyze the clinicopathologic features, melanoma-specific ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content="@ncbi">


<meta name="ncbi_nwds_ver" content="1.1.9-2"><meta name="ncbi_nwds" content="yes"><script async="1" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/analytics.js"></script><script charset="utf-8" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/12.d0a6cbdbbd5630600180.chunk.js"></script><script charset="utf-8" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/7.cf1c493dffb2d169972c.chunk.js"></script><script charset="utf-8" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/1.be767510a0dcd247d2ba.chunk.js"></script></head>
<body id="ui-ncbiexternallink-3">

   
    
        <button class="back-to-top back-to-top--bottom visible" data-ga-category="pagination" data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/favicon-57.png" alt="U.S. flag">
        <p>An official website of the United States government</p>
        <button class="usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top">
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img class="usa-banner-icon usa-media_block-img" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/icon-dot-gov.svg" alt="Dot gov">
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br>
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img class="usa-banner-icon usa-media_block-img" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/icon-https.svg" alt="Https">
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br>
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section><section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/AgencyLogo.svg" alt="NIH NLM Logo">
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F" class="usa-button header-button" style="" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" aria-haspopup="true" aria-expanded="false">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true" tabindex="-1" aria-modal="true" style="display: none;">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="https://www.ncbi.nlm.nih.gov/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="https://www.ncbi.nlm.nih.gov/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov/" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="https://www.ncbi.nlm.nih.gov/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>

<!-- ========== END HEADER ========== -->

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/" title="Home" aria-label="Home"></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1" aria-hidden="true">
            <div role="search" class="pmc-header--stretch">
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <span class="twitter-typeahead ncbi-autocomplete"><input required="required" autocomplete-url="/pmc/autocomplete/pmc/" placeholder="Search PMC Full-Text Archive" id="pmc-search" type="search" name="term" class="tt-input" spellcheck="false" dir="auto" style="position: relative; vertical-align: top;" aria-owns="pmc-search_listbox" role="combobox" aria-autocomplete="list" aria-expanded="false"><span role="status" aria-live="polite" style="position: absolute; padding: 0px; border: 0px; height: 1px; width: 1px; margin-bottom: -1px; margin-right: -1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); white-space: nowrap;"></span><pre aria-hidden="true" style="position: absolute; visibility: hidden; white-space: pre; font-family: Roboto, &quot;Helvetica Neue&quot;, Arial, Tahoma; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;"></pre><div role="listbox" class="tt-menu" id="pmc-search_listbox" style="position: absolute; top: 100%; left: 0px; z-index: 100; display: none;"><div role="presentation" class="tt-dataset tt-dataset-0"></div></div></span>
                  <i class="clear-btn"></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/about/userguide/" data-ga-action="featured_link" data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item">
                    <a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/3344/">Cancer Control</a>
                </li>
            
                <li class="usa-breadcrumb__list-item">
                    <a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/issues/383838/">v.28; Jan-Dec 2021</a>
                </li>
            
                <li class="usa-breadcrumb__list-item" aria-current="page">
                    PMC8581784
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/pdf/10.1177_10732748211053567.pdf" class="int-view">PDF (762K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp" aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open" data-all-citations-url="/pmc/resources/citations/8581784/" data-citation-style="nlm" data-download-format-link="/pmc/resources/citations/8581784/export/">
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/overlay-block.css">
<div class="collections-button-container" data-article-id="8581784" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_button" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F%23open-collections-dialog" data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay collections-dialog-overlay" role="dialog">
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true" role="document">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form" class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/pmc/list-existing-collections/" data-add-to-existing-collection-url="/pmc/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="aD759maqipFBjZvd8ORziZ4z6iiwRkGIhG02PkwkvUFWHh8miJUove1z8U2VEg72">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio" id="collections-action-dialog-new-header " class="collections-new" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio" id="collections-action-dialog-existing-header " class="collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="collections-action-add-to-new" pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing" class="action-panel-selector collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($(&#39;.collections-action-add-to-existing&#39;).val() === &#39;Favorites&#39;) ? &#39;Favorites&#39; : &#39;non_favorites_collection&#39;">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore="" data-ga-category="collections_button" data-ga-action="click" data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel" aria-label="Close &#39;Add to Collections&#39; panel" ref="linksrc=close_collections_panel" aria-controls="collections-action-panel" aria-expanded="false" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F&amp;text=Acral%20Lentiginous%20Melanoma%3A%20A%20United%20States%20Multi-Center%20Substage%20Survival%20Analysis" alt="Share on Twitter" aria-expanded="false" aria-haspopup="true"><i class="fa fa-twitter fa-stack-1x">&nbsp;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F" alt="Share on Facebook" aria-expanded="false" aria-haspopup="true"><i class="fa fa-facebook fa-stack-1x">&nbsp;</i></a></li>
                <li>
                    <div class="share-permalink dropdown-block">
                        <button class="trigger" alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg">
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container">
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="similar-articles-accordion-header" aria-expanded="false" data-action-open="open_similar_articles" data-action-close="close_similar_articles">
                        Similar articles
                    </button>
                    <div data-source-url="/pmc/resources/similar-article-links/34752172/" class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="cited-by-accordion-header" aria-expanded="false" data-action-open="open_cited_by" data-action-close="close_cited_by">
                        Cited by other articles
                    </button>
                    <div data-source-url="/pmc/resources/cited-by-links/34752172/" class="usa-accordion-content pmc-sidebar__resources--citations" id="cited-by-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="links-accordion-header" aria-expanded="false" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link">
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8581784/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item">
                    <a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/3344/">Cancer Control</a>
                </li>
            
                <li class="usa-breadcrumb__list-item">
                    <a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/issues/383838/">v.28; Jan-Dec 2021</a>
                </li>
            
                <li class="usa-breadcrumb__list-item" aria-current="page">
                    PMC8581784
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/logo-ccon.gif" alt="Logo of ccon" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,500,75" alt="Cancer Control : Journal of the Moffitt Cancer Center" title="Cancer Control : Journal of the Moffitt Cancer Center" href="http://journals.sagepub.com/home/ccx" ref="reftype=publisher&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"></map></div> 
                
            
        </section>
        <section role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden,.nomenu&#39;" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span role="menubar"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" role="menuitem" aria-expanded="false" aria-haspopup="true">Cancer Control.</a></span> 2021 Jan-Dec; 28: 10732748211053567. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2021 Nov 9. </span>  <span class="doi"><span>doi:&nbsp;</span><a href="https://doi.org/10.1177%2F10732748211053567" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1177/10732748211053567</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8581784</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34752172">34752172</a></div></div></div><h1 class="content-title">Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kolla%20AM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612583027648" co-class="co-affbox">Avani M. Kolla</a>, BPhil,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vitiello%20GA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612583024784" co-class="co-affbox">Gerardo A. Vitiello</a>, MD,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Friedman%20EB%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612565473920" co-class="co-affbox">Erica B. Friedman</a>, MD,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612565471680" co-class="co-affbox">James Sun</a>, MD,<sup>3,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Potdar%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612581719280" co-class="co-affbox">Aishwarya Potdar</a>, MS,<sup>3,</sup><sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Daou%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612581716304" co-class="co-affbox">Hala Daou</a>, BS,<sup>3,</sup><sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Farrow%20NE%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612574121280" co-class="co-affbox">Norma E. Farrow</a>, MD,<sup>5</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Farley%20CR%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612574119040" co-class="co-affbox">Clara R. Farley</a>, MD,<sup>6</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vetto%20JT%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612562084512" co-class="co-affbox">John T. Vetto</a>, MD,<sup>7</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Han%20D%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612562082272" co-class="co-affbox">Dale Han</a>, MD,<sup>7</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tariq%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612562080032" co-class="co-affbox">Marvi Tariq</a>, MD,<sup>6</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Beasley%20GM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612578402864" co-class="co-affbox">Georgia M Beasley</a>, MD,<sup>5</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Contreras%20CM%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612578400624" co-class="co-affbox">Carlo M. Contreras</a>, MD,<sup>8,</sup><sup>†</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lowe%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612618655824" co-class="co-affbox">Michael Lowe</a>, MD,<sup>6</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zager%20JS%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612618653584" co-class="co-affbox">Jonathan S. Zager</a>, MD,<sup>3,</sup><sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Osman%20I%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612585521808" co-class="co-affbox">Iman Osman</a>, MD,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berman%20RS%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612585519568" co-class="co-affbox">Russell S. Berman</a>, MD,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liebman%20TN%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612585517328" co-class="co-affbox">Tracey N. Liebman</a>, MD,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Stein%20JA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612582572048" co-class="co-affbox">Jennifer A. Stein</a>, MD PhD,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20AY%5BAuthor%5D" class="affpopup" co-rid="_co_idm140612582569808" co-class="co-affbox">Ann Y. Lee</a>, MD<sup>2</sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140612583027648"><h3 class="no_margin">Avani M. Kolla</h3><p><sup>1</sup>The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kolla%20AM%5BAuthor%5D">Avani M. Kolla</a></div></div><div id="_co_idm140612583024784"><h3 class="no_margin">Gerardo A. Vitiello</h3><p><sup>2</sup>Department of Surgery, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vitiello%20GA%5BAuthor%5D">Gerardo A. Vitiello</a></div></div><div id="_co_idm140612565473920"><h3 class="no_margin">Erica B. Friedman</h3><p><sup>2</sup>Department of Surgery, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Friedman%20EB%5BAuthor%5D">Erica B. Friedman</a></div></div><div id="_co_idm140612565471680"><h3 class="no_margin">James Sun</h3><p><sup>3</sup>Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20J%5BAuthor%5D">James Sun</a></div></div><div id="_co_idm140612581719280"><h3 class="no_margin">Aishwarya Potdar</h3><p><sup>3</sup>Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA</p><p><sup>4</sup>Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Potdar%20A%5BAuthor%5D">Aishwarya Potdar</a></div></div><div id="_co_idm140612581716304"><h3 class="no_margin">Hala Daou</h3><p><sup>3</sup>Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA</p><p><sup>4</sup>Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Daou%20H%5BAuthor%5D">Hala Daou</a></div></div><div id="_co_idm140612574121280"><h3 class="no_margin">Norma E. Farrow</h3><p><sup>5</sup>Department of Surgery, Duke University, Durham, NC, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Farrow%20NE%5BAuthor%5D">Norma E. Farrow</a></div></div><div id="_co_idm140612574119040"><h3 class="no_margin">Clara R. Farley</h3><p><sup>6</sup>Department of Surgery, Emory University, Atlanta, GA, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Farley%20CR%5BAuthor%5D">Clara R. Farley</a></div></div><div id="_co_idm140612562084512"><h3 class="no_margin">John T. Vetto</h3><p><sup>7</sup>Department of Surgery, Oregon Health &amp; Science University, Portland, OR, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Vetto%20JT%5BAuthor%5D">John T. Vetto</a></div></div><div id="_co_idm140612562082272"><h3 class="no_margin">Dale Han</h3><p><sup>7</sup>Department of Surgery, Oregon Health &amp; Science University, Portland, OR, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Han%20D%5BAuthor%5D">Dale Han</a></div></div><div id="_co_idm140612562080032"><h3 class="no_margin">Marvi Tariq</h3><p><sup>6</sup>Department of Surgery, Emory University, Atlanta, GA, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tariq%20M%5BAuthor%5D">Marvi Tariq</a></div></div><div id="_co_idm140612578402864"><h3 class="no_margin">Georgia M Beasley</h3><p><sup>5</sup>Department of Surgery, Duke University, Durham, NC, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Beasley%20GM%5BAuthor%5D">Georgia M Beasley</a></div></div><div id="_co_idm140612578400624"><h3 class="no_margin">Carlo M. Contreras</h3><p><sup>8</sup>Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Contreras%20CM%5BAuthor%5D">Carlo M. Contreras</a></div></div><div id="_co_idm140612618655824"><h3 class="no_margin">Michael Lowe</h3><p><sup>6</sup>Department of Surgery, Emory University, Atlanta, GA, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lowe%20M%5BAuthor%5D">Michael Lowe</a></div></div><div id="_co_idm140612618653584"><h3 class="no_margin">Jonathan S. Zager</h3><p><sup>3</sup>Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA</p><p><sup>4</sup>Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zager%20JS%5BAuthor%5D">Jonathan S. Zager</a></div></div><div id="_co_idm140612585521808"><h3 class="no_margin">Iman Osman</h3><p><sup>1</sup>The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Osman%20I%5BAuthor%5D">Iman Osman</a></div></div><div id="_co_idm140612585519568"><h3 class="no_margin">Russell S. Berman</h3><p><sup>2</sup>Department of Surgery, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berman%20RS%5BAuthor%5D">Russell S. Berman</a></div></div><div id="_co_idm140612585517328"><h3 class="no_margin">Tracey N. Liebman</h3><p><sup>1</sup>The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liebman%20TN%5BAuthor%5D">Tracey N. Liebman</a></div></div><div id="_co_idm140612582572048"><h3 class="no_margin">Jennifer A. Stein</h3><p><sup>1</sup>The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Stein%20JA%5BAuthor%5D">Jennifer A. Stein</a></div></div><div id="_co_idm140612582569808"><h3 class="no_margin">Ann Y. Lee</h3><p><sup>2</sup>Department of Surgery, NYU Langone Health, New York, NY, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20AY%5BAuthor%5D">Ann Y. Lee</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" class="pmctoggle" rid="idm140612584869008_ai">Author information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" class="pmctoggle" rid="idm140612584869008_cpl">Copyright and License information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140612584869008_ai" style="display:none"><div class="fm-affl" id="aff1-10732748211053567"><sup>1</sup>The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA</div><div class="fm-affl" id="aff2-10732748211053567"><sup>2</sup>Department of Surgery, NYU Langone Health, New York, NY, USA</div><div class="fm-affl" id="aff3-10732748211053567"><sup>3</sup>Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA</div><div class="fm-affl" id="aff4-10732748211053567"><sup>4</sup>Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA</div><div class="fm-affl" id="aff5-10732748211053567"><sup>5</sup>Department of Surgery, Duke University, Durham, NC, USA</div><div class="fm-affl" id="aff6-10732748211053567"><sup>6</sup>Department of Surgery, Emory University, Atlanta, GA, USA</div><div class="fm-affl" id="aff7-10732748211053567"><sup>7</sup>Department of Surgery, Oregon Health &amp; Science University, Portland, OR, USA</div><div class="fm-affl" id="aff8-10732748211053567"><sup>8</sup>Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA</div><div id="corresp1-10732748211053567">Ann Y. Lee, MD, Department of Surgery, NYU Langone Medical Center, 462 1st Avenue, 15th Floor, NBV15S6, New York, NY 10016-4576, USA. Email: <a href="mailto:dev@null" data-email="gro.enognaluyn@eel.nna" class="oemail">gro.enognaluyn@eel.nna</a></div><div id="fn1-10732748211053567"><sup>*</sup>Current Affiliation: Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH 44106-1716, USA</div><div id="fn2-10732748211053567"><sup>†</sup>Current Affiliation: Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210-1132, USA</div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140612584869008_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright</a> © The Author(s) 2021</div><div class="license half_rhythm">This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://creativecommons.org/licenses/by-nc/4.0/</a>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<a href="https://us.sagepub.com/en-us/nam/open-access-at-sage" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://us.sagepub.com/en-us/nam/open-access-at-sage</a>).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.s.b.m" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="abstract-a.s.b.mtitle">Abstract</h2><!--article-meta--><div><div id="sec-a.s.b.m.a" class="sec sec-first"><h3 id="sec-a.s.b.m.atitle">Background</h3><p class="p p-first-last">Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care.</p></div><div id="sec-a.s.b.m.b" class="sec"><h3 id="sec-a.s.b.m.btitle">Objectives</h3><p class="p p-first-last">To analyze the clinicopathologic features, melanoma-specific survival, and recurrence-free survival by substage in a large, multi-institutional cohort of primary acral lentiginous melanoma patients.</p></div><div id="sec-a.s.b.m.c" class="sec"><h3 id="sec-a.s.b.m.ctitle">Methods</h3><p class="p p-first-last">Retrospective review of the United States Melanoma Consortium database, a multi-center prospectively collected database of acral lentiginous melanoma patients treated between January 2000 and December 2017.</p></div><div id="sec-a.s.b.m.d" class="sec"><h3 id="sec-a.s.b.m.dtitle">Results</h3><p class="p p-first-last">Of the 433 primary acral lentiginous melanoma patients identified (median [range] age: 66 [8–97] years; 53% female, 83% white), 66% presented with stage 0–2 disease and the median time of follow-up for the 392 patients included in the survival analysis was 32.5 months (range: 0–259). The 5-year melanoma-specific survivals by stage were 0 = 100%, I = 93.8%, II = 76.2%, III = 63.4%, IIIA = 80.8%, and IV = 0%. Thicker Breslow depth ((HR) = 1.13; 95% CI = 1.05–1.21; <em>P</em> &lt; .001)) and positive nodal status ((HR) = 1.79; 95% CI = 1.00–3.22; <em>P</em> = .050)) were independent prognostic factors for melanoma-specific survival. Breslow depth ((HR = 1.13; 95% CI = 1.07–1.20; <em>P</em> &lt; .001), and positive nodal status (HR = 2.12; 95% CI = 1.38–3.80; <em>P</em> = .001) were also prognostic factors for recurrence-free survival.</p></div><div id="sec-a.s.b.m.e" class="sec sec-last"><h3 id="sec-a.s.b.m.etitle">Conclusion</h3><p class="p p-first-last">In this cohort of patients, acral lentiginous melanoma was associated with poor outcomes even in early stage disease, consistent with prior reports. Stage IIB and IIC disease were associated with particularly low melanoma-specific and recurrence-free survival. This suggests that studies investigating adjuvant therapies in stage II patients may be especially valuable in acral lentiginous melanoma patients.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">melanoma, skin cancer, outcomes, substage, acral lentiginous melanoma</span></div></div><div id="sec6-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec6-10732748211053567title">Introduction</h2><p class="p p-first">Acral lentiginous melanoma (ALM) is a subtype of melanoma predominantly occurring on palmar, plantar, and subungual skin. Though only accounting for 2–3% of all melanomas, ALM disproportionately affects African American, Hispanic, and Asian populations.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr2-10732748211053567" rid="bibr2-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">2</a></sup> It is the most common subtype in those with darker skin types and needs to remain a significant diagnostic consideration in these individuals.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup></p><p>The prognosis of patients with ALM is worse compared to patients with non-acral melanoma.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>
</sup> It has been suggested that decreased survival may be due to a delay in diagnosis, leading to increased tumor thickness and advanced stage at presentation.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr4-10732748211053567" rid="bibr4-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr5-10732748211053567" rid="bibr5-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr6-10732748211053567" rid="bibr6-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567" rid="bibr7-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr8-10732748211053567" rid="bibr8-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr9-10732748211053567" rid="bibr9-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr10-10732748211053567" rid="bibr10-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr11-10732748211053567" rid="bibr11-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr12-10732748211053567" rid="bibr12-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> The later stage at diagnosis may be due to initial misdiagnosis, atypical location compared to superficial spreading melanoma, unusual presentation, or delay in seeking care.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> However, recent studies have suggested that ALM patients may not necessarily present at a later stage than non-ALM patients.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>
</sup> Additional possibilities for survival disparities include genomic differences between ALM (likely non-ultraviolet (UV)-induced) and cutaneous melanoma (UV-induced).<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr14-10732748211053567" rid="bibr14-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">14</a>
</sup> The exact cause of the poor prognosis associated with ALM therefore remains unknown.</p><p class="p p-last">A thorough description of the diagnostic, management, and recurrence patterns may uncover key features that help explain the poor survival associated with ALM. Unfortunately, many previous studies examining ALM prognosis have been limited by small sample sizes and/or ethnically homogenous populations (i.e., exclusively in Japanese or Caucasian patients) in single-institution cohorts,<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567" rid="bibr7-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr8-10732748211053567" rid="bibr8-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr9-10732748211053567" rid="bibr9-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr10-10732748211053567" rid="bibr10-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr11-10732748211053567" rid="bibr11-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr12-10732748211053567" rid="bibr12-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> and the few larger cohort studies have not examined recurrence patterns.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr5-10732748211053567" rid="bibr5-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr6-10732748211053567" rid="bibr6-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">6</a></sup> In this study, we used a large, multi-institutional melanoma database to not only characterize the presenting clinicopathologic features and recurrence patterns of ALM, but also analyze melanoma-specific survival (MSS) and recurrence-free survival (RFS) by pathologic American Joint Cancer Committee (AJCC) eighth ed. stage and substage, which highlights important prognostic features when caring for patients with ALM.</p></div><div id="sec7-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec7-10732748211053567title">Methods</h2><p class="p p-first">The United States Melanoma Consortium database, a prospectively collected database from six institutions (New York University Langone Health, Moffitt Cancer Center, Emory University, Oregon Health and Science University, University of Alabama Birmingham, and Duke University), was used to perform a retrospective study of 433 patients with primary ALM managed surgically at one of the above institutions between January 2000 and December 2017. Patients who presented with recurrent ALM were excluded. All institutions received approval for this study and waiver of consent from their respective institutional review boards (Emory IRB#00101435)</p><p>Data collected included demographics, comorbidities, clinical characteristics, diagnostic work-up, histopathology of final excision specimen, postoperative outcomes, systemic treatment/radiotherapy, disease recurrence and survival data. All tumors underwent wide local excision with margins based on National Comprehensive Cancer Network (NCCN) guidelines.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr15-10732748211053567" rid="bibr15-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">15</a>
</sup> Pathologic TNM stage was used to reclassify patients based on AJCC eighth edition staging.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567" rid="bibr16-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>
</sup> Survival time was calculated as months between date of surgery and date of last follow-up or death. Follow-up included clinical exams with the surgeon, oncologist, and/or dermatologist and surveillance imaging at the discretion of the treating physician. Forty-one patients with inadequate details on pathologic stage or date of surgery were excluded from survival analyses. Of the patients included, substage could not be determined for two of the stage II patients.</p><p class="p p-last">Clinical characteristics analyzed included age, sex, patient-reported race, and location of lesion. Race was included to determine whether or not it is a prognostic factor for survival. Histopathologic characteristics analyzed included AJCC eighth edition stage, Breslow thickness of final specimen, presence of ulceration, presence of mitoses, and lymph node status. Five-year MSS and RFS rates and curves were generated using the Kaplan–Meier method. Melanoma-related deaths were determined based on review of death certificates, inquiry to patient’s treating physicians, known stage IV disease resulting in multisystem organ failure, or documentation of hospice care for advanced melanoma. Recurrence was defined as detection of disease in patients whom had no residual disease following intervention. For stage III disease, patients who had undergone completion lymph node dissection (CLND) were considered to be without residual disease; those who had not undergone CLND were assumed to have no residual disease after sentinel lymph node biopsy (SLNB) unless otherwise documented, as data shows that only 11.5% of these patients have residual disease.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr17-10732748211053567" rid="bibr17-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">17</a>
</sup> Stage IV patients were excluded from RFS analysis. Univariate Cox regression model was used to determine if any of the clinicopathologic characteristics were associated with MSS or RFS. Proportional hazards assumption was tested using Kaplan–Meier curves and time-dependent covariate Cox regression models Characteristics significant (<em>P</em> value &lt;.05) on univariate analysis were included in the multivariable Cox proportional hazards model to identify prognostic factors. Data analysis was performed using SPSS software (IBM Inc. Armonk, NY).</p></div><div id="sec8-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec8-10732748211053567title">Results</h2><div id="sec9-10732748211053567" class="sec sec-first"><h3 id="sec9-10732748211053567title">Clinicopathologic Characteristics</h3><p class="p p-first-last">Overall, 392 patients with primary ALM were analyzed (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table1-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table1-10732748211053567" rid-ob="ob-table1-10732748211053567" co-legend-rid=""><span>Table 1</span></a>), of which 282 (72%) presented with localized disease (stage 0 to II). Median age was 65&nbsp;years (range: 8–97), and 54% of patients were female. Eighty-three percent of patients were white, and 77% presented with a plantar surface lesion. One hundred and six tumors (26%) were less than 1.0&nbsp;mm thick at the time of surgery. Females were more likely than males to present with melanomas less than 1&nbsp;mm (33.8% and 19.2%; <em>P</em> &lt; .001). Of 110 stage III and IV patients, 22 (20%) were treated with adjuvant therapy, of which seven were treated with immunotherapy. Race was not associated with stage at presentation.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="table1-10732748211053567"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p>Clinical and Histopathologic Characteristic.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">All patients (n = 433)</th><th align="center" rowspan="1" colspan="1">Patients included in survival analysis (n = 392)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Age (years), mean; Median (range)</td><td align="left" rowspan="1" colspan="1">65; 66 (8–97)</td><td align="left" rowspan="1" colspan="1">63; 65 (8–97)</td></tr><tr><td align="left" colspan="3" rowspan="1">Gender n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Female</td><td align="left" rowspan="1" colspan="1">231 (53.3)</td><td align="left" rowspan="1" colspan="1">210 (53.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Male</td><td align="left" rowspan="1" colspan="1">202 (46.7)</td><td align="left" rowspan="1" colspan="1">182 (46.4)</td></tr><tr><td align="left" colspan="3" rowspan="1">Race n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> White, non-Hispanic</td><td align="left" rowspan="1" colspan="1">358 (82.7)</td><td align="left" rowspan="1" colspan="1">326 (83.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Black</td><td align="left" rowspan="1" colspan="1">51 (11.8)</td><td align="left" rowspan="1" colspan="1">46 (11.7)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Hispanic</td><td align="left" rowspan="1" colspan="1">12 (2.8)</td><td align="left" rowspan="1" colspan="1">11 (2.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Asian/Pacific islander</td><td align="left" rowspan="1" colspan="1">7 (1.6)</td><td align="left" rowspan="1" colspan="1">5 (1.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Not reported</td><td align="left" rowspan="1" colspan="1">5 (1.2)</td><td align="left" rowspan="1" colspan="1">4 (1.0)</td></tr><tr><td align="left" colspan="3" rowspan="1">Location of lesion n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Plantar</td><td align="left" rowspan="1" colspan="1">331 (76.4)</td><td align="left" rowspan="1" colspan="1">302 (77.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Palmar</td><td align="left" rowspan="1" colspan="1">34 (7.9)</td><td align="left" rowspan="1" colspan="1">29 (7.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Subungual</td><td align="left" rowspan="1" colspan="1">68 (15.7)</td><td align="left" rowspan="1" colspan="1">61 (15.6)</td></tr><tr><td align="left" colspan="3" rowspan="1">Ulceration n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">152 (35.1)</td><td align="left" rowspan="1" colspan="1">138 (35.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">230 (53.1)</td><td align="left" rowspan="1" colspan="1">212 (54.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Not reported<sup>
a
</sup></td><td align="left" rowspan="1" colspan="1">51 (11.8)</td><td align="left" rowspan="1" colspan="1">42 (10.7)</td></tr><tr><td align="left" colspan="3" rowspan="1">Mitoses n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">267 (61.7)</td><td align="left" rowspan="1" colspan="1">239 (61.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">82 (18.9)</td><td align="left" rowspan="1" colspan="1">77 (19.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Not reported</td><td align="left" rowspan="1" colspan="1">84 (19.4)</td><td align="left" rowspan="1" colspan="1">76 (19.4)</td></tr><tr><td align="left" colspan="3" rowspan="1">Nodal status n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Positive</td><td align="left" rowspan="1" colspan="1">115 (26.5)</td><td align="left" rowspan="1" colspan="1">111 (28.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Negative</td><td align="left" rowspan="1" colspan="1">213 (49.2)</td><td align="left" rowspan="1" colspan="1">203 (51.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Sentinel lymph node biopsy not indicated (Tis or T1a)</td><td align="left" rowspan="1" colspan="1">105 (24.3)</td><td align="left" rowspan="1" colspan="1">78 (19.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Breslow thickness (mm) (n= 427), mean; Median (range)</td><td align="left" rowspan="1" colspan="1">2.50; 1.80 (0 to 19)</td><td align="left" rowspan="1" colspan="1">2.80; 1.7 (0 to 19)</td></tr><tr><td align="left" colspan="3" rowspan="1">Stage at presentation n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> 0</td><td align="left" rowspan="1" colspan="1">19 (4.4)</td><td align="left" rowspan="1" colspan="1">19 (4.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"> I</td><td align="left" rowspan="1" colspan="1">151 (34.9)</td><td align="left" rowspan="1" colspan="1">147 (37.5)</td></tr><tr><td align="left" rowspan="1" colspan="1"> II</td><td align="left" rowspan="1" colspan="1">118 (27.2)</td><td align="left" rowspan="1" colspan="1">116 (29.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"> III</td><td align="left" rowspan="1" colspan="1">110 (25.4)</td><td align="left" rowspan="1" colspan="1">108 (27.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"> IV</td><td align="left" rowspan="1" colspan="1">5 (1.2)</td><td align="left" rowspan="1" colspan="1">2 (.5)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Incomplete</td><td align="left" rowspan="1" colspan="1">30 (6.9)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="3" rowspan="1">Therapy for stage III and IV n (%)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Immunotherapy</td><td align="left" rowspan="1" colspan="1">7 (6.1)</td><td align="left" rowspan="1" colspan="1">7 (6.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Interferon</td><td align="left" rowspan="1" colspan="1">9 (7.8)</td><td align="left" rowspan="1" colspan="1">9 (8.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Chemotherapy</td><td align="left" rowspan="1" colspan="1">5 (4.3)</td><td align="left" rowspan="1" colspan="1">2 (1.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Vaccine trial</td><td align="left" rowspan="1" colspan="1">4 (3.5)</td><td align="left" rowspan="1" colspan="1">4 (3.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"> Completion lymph node dissection</td><td align="left" rowspan="1" colspan="1">67 (58.3)</td><td align="left" rowspan="1" colspan="1">67 (60.9)</td></tr><tr><td align="left" rowspan="1" colspan="1"> None</td><td align="left" rowspan="1" colspan="1">35 (30.4)</td><td align="left" rowspan="1" colspan="1">33 (30)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140612560907648"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table1-10732748211053567/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="table-fn1-10732748211053567"><p class="p p-first-last"><sup>a</sup>Ulceration status was not required to stage 30 patients; substage could not be determined for two patients; ulceration status from biopsy was used to stage the remaining ten patients.</p></div></div></div></div><div id="sec10-10732748211053567" class="sec"><h3 id="sec10-10732748211053567title">Melanoma-Specific Survival by Stage</h3><p class="p p-first-last">The median time to follow up for the 392 patients included was 32&nbsp;months (range 0–259) Overall 5-year MSS was 78.1% (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1-10732748211053567" rid-ob="ob-fig1-10732748211053567" co-legend-rid="lgnd_fig1-10732748211053567"><span>Figure 1</span></a>) and by stage were stage 0 = 100%, stage I = 93.8%, IA = 94.2%, IB = 93.4%, II = 76.2%, IIA = 96.8%, IIB = 73.2%, IIC = 63.2%, III = 63.4%, IIIA = 80.8%, IIIB = 79.5%, IIIC = 56.5%, IIID = 44.4%, and IV = 0% (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table2-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table2-10732748211053567" rid-ob="ob-table2-10732748211053567" co-legend-rid=""><span>Table 2</span></a>). The percent of melanoma-related deaths that occurred within 3&nbsp;years after surgery were 9.1% for stage IIB, 40% for IIC, 25% for IIIA, 66.7% for IIIB, and 89.5% for IIIC. All but 2 stage IIB and IIC patients had sentinel lymph node biopsies performed.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1-10732748211053567" co-legend-rid="lgnd_fig1-10732748211053567"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/" target="figure" rid-figpopup="fig1-10732748211053567" rid-ob="ob-fig1-10732748211053567"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140612579270336"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/" target="figure" rid-figpopup="fig1-10732748211053567" rid-ob="ob-fig1-10732748211053567"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8581784_10.1177_10732748211053567-fig1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.
Object name is 10.1177_10732748211053567-fig1.jpg" title="Click on image to zoom" class="tileshop" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/10.1177_10732748211053567-fig1.jpg"></a></div><div class="largeobj-link align_right" id="largeobj_idm140612579270336" style="display: none;"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_fig1-10732748211053567"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/" target="figure" rid-figpopup="fig1-10732748211053567" rid-ob="ob-fig1-10732748211053567">Figure 1.</a></div><!--caption a7--><div class="caption"><p>Kaplan–meier curves for 5-year melanoma-specific survival stratified by pathologic AJCC eighth edition stage (A) and substage (B) and for 5-year recurrence-free survival stratified by stage (C) and substage (D).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="table2-10732748211053567"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p>Melanoma-Specific Survival and Recurrence-Free Survival Rates by AJCC Eighth Edition Stage and Substage.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"></th><th align="center" colspan="2" rowspan="1">Current series (n = 392); AJCC 8th ed.</th><th align="center" rowspan="1" colspan="1">Bello et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>
</sup> (n = 281); AJCC 7th ed.</th><th align="center" rowspan="1" colspan="1">Bradford et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>
</sup> (n = 1178); AJCC 6th ed.</th><th align="center" rowspan="1" colspan="1">AJCC 8th ed. Staging manual</th></tr><tr><th align="left" rowspan="1" colspan="1">Stage</th><th align="left" rowspan="1" colspan="1">n (%)</th><th align="left" rowspan="1" colspan="1">5-yr MSS for ALM</th><th align="left" rowspan="1" colspan="1">5-yr MSS for ALM<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>
</sup></th><th align="left" rowspan="1" colspan="1">5-yr MSS for ALM<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>
</sup></th><th align="left" rowspan="1" colspan="1">5-year MSS for CM<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567" rid="bibr16-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>
</sup></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">19 (4.8)</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">147 (37.5)</td><td align="left" rowspan="1" colspan="1">93.8</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">98.8</td><td align="center" rowspan="1" colspan="1">98</td></tr><tr><td align="left" rowspan="1" colspan="1">IA</td><td align="left" rowspan="1" colspan="1">89 (22.7)</td><td align="left" rowspan="1" colspan="1">94.2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">99</td></tr><tr><td align="left" rowspan="1" colspan="1">IB</td><td align="left" rowspan="1" colspan="1">58 (14.8)</td><td align="left" rowspan="1" colspan="1">93.4</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">97</td></tr><tr><td align="left" rowspan="1" colspan="1">II<sup>
a
</sup></td><td align="left" rowspan="1" colspan="1">116 (29.6)</td><td align="left" rowspan="1" colspan="1">76.2</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">85.8</td><td align="center" rowspan="1" colspan="1">90</td></tr><tr><td align="left" rowspan="1" colspan="1">IIA</td><td align="left" rowspan="1" colspan="1">41 (10.5)</td><td align="left" rowspan="1" colspan="1">96.8</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">94</td></tr><tr><td align="left" rowspan="1" colspan="1">IIB</td><td align="left" rowspan="1" colspan="1">47 (12.0)</td><td align="left" rowspan="1" colspan="1">73.2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">87</td></tr><tr><td align="left" rowspan="1" colspan="1">IIC</td><td align="left" rowspan="1" colspan="1">26 (6.6)</td><td align="left" rowspan="1" colspan="1">63.2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">82</td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">108 (27.6)</td><td align="left" rowspan="1" colspan="1">63.4</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">61.2</td><td align="center" rowspan="1" colspan="1">77</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIA</td><td align="left" rowspan="1" colspan="1">14 (3.6)</td><td align="left" rowspan="1" colspan="1">80.8</td><td align="center" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">93</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIB</td><td align="left" rowspan="1" colspan="1">17 (4.3)</td><td align="left" rowspan="1" colspan="1">79.5</td><td align="center" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">83</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIC</td><td align="left" rowspan="1" colspan="1">68 (17.6)</td><td align="left" rowspan="1" colspan="1">56.5</td><td align="center" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">69</td></tr><tr><td align="left" rowspan="1" colspan="1">IIID</td><td align="left" rowspan="1" colspan="1">9 (2.3)</td><td align="left" rowspan="1" colspan="1">44.4</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">2 (.5)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">22.2</td><td align="center" rowspan="1" colspan="1">—</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage</td><td align="left" rowspan="1" colspan="1">n (%)</td><td align="left" rowspan="1" colspan="1">5-year RFS for ALM</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">19 (4.9)</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">147 (38.3)</td><td align="left" rowspan="1" colspan="1">90.3</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IA</td><td align="left" rowspan="1" colspan="1">89 (23.2)</td><td align="left" rowspan="1" colspan="1">90.7</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IB</td><td align="left" rowspan="1" colspan="1">58 (15.1)</td><td align="left" rowspan="1" colspan="1">89.7</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">116 (30.2)</td><td align="left" rowspan="1" colspan="1">50.1</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIA</td><td align="left" rowspan="1" colspan="1">41 (10.7)</td><td align="left" rowspan="1" colspan="1">67.8</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIB</td><td align="left" rowspan="1" colspan="1">47 (12.2)</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIC</td><td align="left" rowspan="1" colspan="1">26 (6.8)</td><td align="left" rowspan="1" colspan="1">38.3</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">100 (26.0)</td><td align="left" rowspan="1" colspan="1">38.2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIIA</td><td align="left" rowspan="1" colspan="1">14 (3.6)</td><td align="left" rowspan="1" colspan="1">55.7</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIIB</td><td align="left" rowspan="1" colspan="1">17 (4.4)</td><td align="left" rowspan="1" colspan="1">50.2</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIIC</td><td align="left" rowspan="1" colspan="1">61 (15.9)</td><td align="left" rowspan="1" colspan="1">33.4</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IIID</td><td align="left" rowspan="1" colspan="1">8 (2.1)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">2 (.5)</td><td align="left" rowspan="1" colspan="1">—</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140612579266656"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table2-10732748211053567/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="table-fn2-10732748211053567"><p class="p p-first-last"><sup>a</sup>Substage could not be determined for two stage II patients; Abbreviations: MSS—Melanoma-Specific Survival, CM—Cutaneous Melanoma, RFS—Recurrence-Free Survival.</p></div></div></div></div><div id="sec11-10732748211053567" class="sec"><h3 id="sec11-10732748211053567title">Recurrence-Free Survival by Stage</h3><p class="p p-first">Eight additional patients were excluded due to unknown date of recurrence (n = 1) or because they had residual disease following intervention (n = 7). Overall 5-year RFS rate for the 384 included patients was 62.8% (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/figure/fig1-10732748211053567/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1-10732748211053567" rid-ob="ob-fig1-10732748211053567" co-legend-rid="lgnd_fig1-10732748211053567"><span>Figure 1</span></a>) with a median time to recurrence of 23&nbsp;months (range: 0–54&nbsp;months). For patients with recurrence who experienced death, median time to recurrence was 15&nbsp;months (range: 0–71&nbsp;months) and median time between detection of recurrence and death was 16&nbsp;months (range: 1–142&nbsp;months). The 5-year RFS was stage 0 = 100%, stage I = 90.3%, IA = 90.7%, IB = 89.7%, II = 50.1%, IIA = 67.8%, IIB = 45.0%, IIC = 38.3%, III = 38.2%, IIIA = 55.7%, IIIB = 50.2%, IIIC = 33.4%, IIID = .0% (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table2-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table2-10732748211053567" rid-ob="ob-table2-10732748211053567" co-legend-rid=""><span>Table 2</span></a>).</p><p class="p p-last">The most common first site of recurrence was in transit/satellite (n = 40; 38.8%), which had a median time to recurrence of 21.5&nbsp;months. Twenty-nine (28.2%) were first detected in regional nodes, 25 (24.2%) in distant sites, and 9 (8.7%) in nodal and distant sites with median times to recurrence of 23, 24, and 19&nbsp;months, respectively. Of patients with nodal recurrences, 16 (55%) had had negative sentinel lymph node biopsies (SLNB) at time of initial treatment. Of the 11 patients who initially had a positive SLNB, four had undergone a completion lymph node dissection at time of initial treatment. The most common sites of first recurrence by substage are summarized in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table3-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table3-10732748211053567" rid-ob="ob-table3-10732748211053567" co-legend-rid=""><span>Table 3</span></a>. Greater than 70% of recurrences occurred within 3&nbsp;years for stage IIB and higher patients. The percent of recurrences that occurred within 5&nbsp;years were 94.7% for stage IIB, 100% for IIC, 83.3% for IIIA, 88.9% for IIIB, and 97.1% for stage IIIC. Thirteen stage IIB and IIC patients had nodal recurrence only with median time to recurrence of 13 [6–71] months. Following recurrence, 11/13 (84.6%) underwent lymph node excision, 9 (69.2) received systemic therapy (interferon, chemotherapy, or immunotherapy), and 4 (30.8) received radiotherapy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="table3-10732748211053567"><h3>Table 3.</h3><!--caption a7--><div class="caption"><p>Site of First Recurrence by AJCC Eighth Edition Substage.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Substage</th><th align="center" rowspan="1" colspan="1">Site</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">% Of patients in substage</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">IA</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.5</td></tr><tr><td align="left" rowspan="1" colspan="1">n = 89</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.2</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">IB</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">n=58&nbsp;</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3.4</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">5.2</td></tr><tr><td align="left" rowspan="1" colspan="1">IIA</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">9.8</td></tr><tr><td align="left" rowspan="1" colspan="1">n=41</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2.4</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4.9</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">17.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IIB</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">8.5</td></tr><tr><td align="left" rowspan="1" colspan="1">n=47</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">21.3</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4.3</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4.3</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">40.4</td></tr><tr><td align="left" rowspan="1" colspan="1">IIC</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">19.2</td></tr><tr><td align="left" rowspan="1" colspan="1">n=26&nbsp;</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">11.5</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">11.5</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">42.3</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIA</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">n = 14</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7.1</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">21.4</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">42.9</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIB</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">41.2</td></tr><tr><td align="left" rowspan="1" colspan="1">n = 17</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5.9</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5.9</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">52.9</td></tr><tr><td align="left" rowspan="1" colspan="1">IIIC</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">18.0</td></tr><tr><td align="left" rowspan="1" colspan="1">n = 61</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">13.1</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">18.0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">6.6</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">57.4</td></tr><tr><td align="left" rowspan="1" colspan="1">IIID</td><td align="left" rowspan="1" colspan="1">In transit/satellite</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">25.0</td></tr><tr><td align="left" rowspan="1" colspan="1">n = 8</td><td align="left" rowspan="1" colspan="1">Nodal</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">25.0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Distant</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">50.0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Nodal + distant</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">100</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140612582278144"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table3-10732748211053567/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec12-10732748211053567" class="sec sec-last"><h3 id="sec12-10732748211053567title">Cox Proportional Hazards Survival Analysis</h3><p class="p p-first-last">On univariate analysis, the presence of ulceration, presence of mitoses, positive nodal status, advanced pathologic stage, and thicker Breslow depth were associated with reduced MSS and RFS (all <em>P</em> &lt; .05) (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table4-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table4-10732748211053567" rid-ob="ob-table4-10732748211053567" co-legend-rid=""><span>Table 4</span></a>). Age, gender, location of lesion, and race were not significantly associated with MSS or RFS. On multivariable Cox proportional hazard modeling, thicker Breslow depth ((Hazard Ratio (HR)=1.13 [95% Confidence Interval (CI) = 1.05–1.21]); <em>P</em> = &lt;.001)) and positive nodal status (HR = 1.79 [1.00–3.22]; <em>P</em> = .05), were identified as independent prognostic factors for reduced MSS (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table5-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table5-10732748211053567" rid-ob="ob-table5-10732748211053567" co-legend-rid=""><span>Table 5</span></a>). Positive nodal status (HR = 2.12 [1.38–3.80]; <em>P</em> = .001), and thicker Breslow depth (HR = 1.13 [1.07–1.20]; <em>P</em> &lt; .001) also remained as independent prognostic factors for RFS. Stage was not included in the multivariate model as it would have confounded with ulceration and Breslow thickness.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="table4-10732748211053567"><h3>Table 4.</h3><!--caption a7--><div class="caption"><p>Cox Proportional Hazards Model for Melanoma-Specific Survival and Recurrence-Free Survival (Univariate Analysis).</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1"></th><th align="center" colspan="2" rowspan="1">Melanoma-specific survival</th><th align="center" colspan="2" rowspan="1">Recurrence-free survival</th></tr><tr><th align="center" rowspan="1" colspan="1">Hazard ratio (95% CI)</th><th align="center" rowspan="1" colspan="1">
<em>P</em>
</th><th align="center" rowspan="1" colspan="1">Hazard ratio (95% CI)</th><th align="center" rowspan="1" colspan="1">
<em>P</em>
</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">1.02 (1.0–1.04)</td><td align="left" rowspan="1" colspan="1">.079</td><td align="left" rowspan="1" colspan="1">1.01 (.997–1.03)</td><td align="left" rowspan="1" colspan="1">.114</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.195</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.94</td></tr><tr><td align="left" rowspan="1" colspan="1"> Male</td><td align="left" rowspan="1" colspan="1">1.42 (.84–2.42)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.984 (.66–1.46)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Female</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Location of lesion</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.257</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.178</td></tr><tr><td align="left" rowspan="1" colspan="1"> Palmar</td><td align="left" rowspan="1" colspan="1">1.54 (.43–5.50)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.66 (.37–1.25)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Plantar</td><td align="left" rowspan="1" colspan="1">2.02 (.86–4.76)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.42 (.98–2.05)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Subungual</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Race</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.62</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.496</td></tr><tr><td align="left" rowspan="1" colspan="1"> Asian/Pacific islander</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.74 (.364–8.31)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Black</td><td align="left" rowspan="1" colspan="1">.52 (.20–1.45)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.925 (.40–2.14)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Hispanic</td><td align="left" rowspan="1" colspan="1">.59 (.08–4.25)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.463 (.097–2.20)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> White, non-Hispanic</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Ulceration</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">3.04 (1.71–5.39)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">2.29 (1.63–3.21)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Unknown</td><td align="left" rowspan="1" colspan="1">.84 (.29–2.49)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.53 (.30–.916)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Mitoses</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>.041</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>.003</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">6.19 (1.49–25.64)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.79 (1.25–2.56)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Unknown</td><td align="left" rowspan="1" colspan="1">5.21 (1.18–23.10)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.56 (1.04–2.33)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Nodal disease status<sup>
a
</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>.001</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">2.53 (1.48–4.33)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">2.96 (1.98–4.43)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Breslow thickness (mm)<sup>
b
</sup></td><td align="left" rowspan="1" colspan="1">1.21 (1.13–1.28)</td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td><td align="left" rowspan="1" colspan="1">1.21 (1.15–1.27)</td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Stage</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> 0</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> I</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> II</td><td align="left" rowspan="1" colspan="1">3.94 (1.46–10.63)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">17.31 (.0–290)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> III</td><td align="left" rowspan="1" colspan="1">6.70 (2.71–18.0)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">32.44 (.0–544)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> IV</td><td align="left" rowspan="1" colspan="1">479.36 (71.3–3224.31)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140612561462464"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table4-10732748211053567/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="table-fn3-10732748211053567"><p class="p p-first-last"><sup>a</sup>Includes patients who had sentinel lymph node biopsy performed or had clinically palpable lymph nodes (n = 314).</p></div><div id="table-fn4-10732748211053567"><p class="p p-first-last"><sup>b</sup>Continuous variable.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="table5-10732748211053567"><h3>Table 5.</h3><!--caption a7--><div class="caption"><p>Cox Proportional Hazards Model for Melanoma-Specific Survival and Recurrence-Free Survival (Multivariate Analysis)<sup>a</sup>.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1"></th><th align="left" colspan="2" rowspan="1">Melanoma-specific survival</th><th align="left" colspan="2" rowspan="1">Recurrence-free survival</th></tr><tr><th align="left" rowspan="1" colspan="1">Hazard ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">
<em>P</em>
</th><th align="left" rowspan="1" colspan="1">Hazard ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">
<em>P</em>
</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Ulceration</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">0.2</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">
<strong>.08</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">1.66 (.89–3.09)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.48 (.94–2.32)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Unknown</td><td align="left" rowspan="1" colspan="1">.73 (.16–3.41)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">.50 (.14–1.72)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Mitoses</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">.15</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">
<strong>.09</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">3.75 (.87–16.15)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">2.43 (.97–6.1)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Unknown</td><td align="left" rowspan="1" colspan="1">4.67 (1.00–21.86)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">3.13 (1.13–8.63)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Nodal disease status</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">
<strong>.05</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">
<strong>.001</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> Present</td><td align="left" rowspan="1" colspan="1">1.79 (1.00–3.22)</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">2.12 (1.38–3.80)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"> Absent</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Breslow thickness (mm)<sup>
b
</sup></td><td align="left" rowspan="1" colspan="1">1.13 (1.05–1.21)</td><td align="center" rowspan="1" colspan="1">
<strong>.001</strong>
</td><td align="left" rowspan="1" colspan="1">1.13 (1.06–1.20)</td><td align="center" rowspan="1" colspan="1">
<strong>&lt;.001</strong>
</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140612582391728"><a target="object" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table5-10732748211053567/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="table-fn5-10732748211053567"><p class="p p-first-last"><sup>a</sup>Includes patients who had sentinel lymph node biopsy performed or had clinically palpable lymph nodes (n = 314).</p></div><div id="table-fn6-10732748211053567"><p class="p p-first-last"><sup>b</sup>Continuous variable.</p></div></div></div></div></div><div id="sec13-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec13-10732748211053567title">Discussion</h2><p class="p p-first">Acral lentiginous melanoma is a rare subtype of melanoma, and survival outcomes are significantly worse when compared to other cutaneous melanomas.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>
</sup> To date, most studies characterizing ALM have been limited in sample size and ethnic diversity.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567" rid="bibr7-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr8-10732748211053567" rid="bibr8-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr9-10732748211053567" rid="bibr9-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr10-10732748211053567" rid="bibr10-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr11-10732748211053567" rid="bibr11-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true"></a>-<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr12-10732748211053567" rid="bibr12-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> In this study, we utilized a large, multi-institutional database to perform an in-depth analysis of ALM diagnosis, management, recurrence patterns, and survival characteristics, which highlights unique ALM stage and substage features that have the potential to identify patients at risk for recurrence and improve outcomes.</p><p>Similar to other studies, our study highlights that ALM is associated with advanced age and plantar location.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr6-10732748211053567" rid="bibr6-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">6</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567" rid="bibr7-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr11-10732748211053567" rid="bibr11-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">11</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> Most primary tumors were &gt;1.0&nbsp;mm (74%) and had mitoses present (61.0%). Histologic ulceration was present in 35.1 and 26.5% had at least one positive node. Tumor thickness was an independent prognostic factor for MSS, which is consistent with prior ALM series.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr6-10732748211053567" rid="bibr6-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">6</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr18-10732748211053567" rid="bibr18-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">18</a></sup> A majority (72%) of our cohort presented with localized (AJCC eighth edition stage 0 to II) disease. In two recent single-institution cohort studies, Bello et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>
</sup> reported that 71% of patients with non-acral melanoma on the extremities presented with localized disease, and Wada et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567" rid="bibr7-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>
</sup> reported this proportion to be 63%, suggesting that ALM patients may not necessarily present at a later stage than non-ALM patients.</p><p>In contrast to the survival patterns in overall cutaneous melanoma,<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567" rid="bibr16-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>
</sup> stage I disease in our cohort was associated with excellent outcomes while stage II was not, suggesting that early stage disease may not necessarily be associated with good prognosis. The trends in our 5-year MSS by stage are consistent with prior reports of ALM patients (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/table/table2-10732748211053567/" target="table" class="fig-table-link figpopup" rid-figpopup="table2-10732748211053567" rid-ob="ob-table2-10732748211053567" co-legend-rid=""><span>Table 2</span></a>).<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567" rid="bibr16-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a></sup> In Bradford et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567" rid="bibr1-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>
</sup>’s population-based analysis of the Surveillance, Epidemiology, and End Results (SEER) registry, they additionally found that after controlling for AJCC stage, survival rates for ALM patients were lower compared to non-ALM patients in stage II and III patients. This suggests that the poorer survival of ALM compared to non-ALM is independent of stage, and further highlights that the worse prognosis in ALM may not be entirely due to advanced disease at presentation. It has been hypothesized that distinct genetic alterations as well as socioeconomic disparities may also contribute to survival differences.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr5-10732748211053567" rid="bibr5-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>
</sup> ALM is genetically distinct in that <em>BRAF</em> mutations have been reported less frequently compared to melanoma that occurs on sun-exposed skin.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr19-10732748211053567" rid="bibr19-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">19</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr20-10732748211053567" rid="bibr20-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">20</a></sup> ALM also has a lower mutation burden compared to melanoma on UV-exposed skin, and thus, fewer actionable targets.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr21-10732748211053567" rid="bibr21-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21</a>
</sup> Studies have also found that ALM more frequently has KIT mutations than non-acral cutaneous melanomas (36 vs 28%, respectively).<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr22-10732748211053567" rid="bibr22-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">22</a>
</sup> However, the relationship between these variations in molecular pathways and prognosis remains poorly understood. Because patients with darker skin comprise a greater proportion of ALM cases compared to non-acral cases, socioeconomic disparities may also play a role.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr23-10732748211053567" rid="bibr23-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">23</a>
</sup> In a more recent analysis of the SEER database, Huang et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr5-10732748211053567" rid="bibr5-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>
</sup> found that non-Hispanic Whites had the highest survival and Blacks had the lowest. After stratifying by stage, this difference in survival remained significant in stage I and stage III patients. In our cohort, the majority of patients were white (83%), which is consistent with the racial distribution of the SEER database. Although race was not a prognostic factor for MSS in our cohort, understanding the underlying socioeconomic factors of such health disparities warrants further investigation.</p><p>In overall cutaneous melanoma, stage IIB and IIC MSS is better than or similar to stage IIIB MSS.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567" rid="bibr16-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>
</sup> In contrast, stage IIB/IIC patients had worse 5-year MSS and RFS compared to IIIB patients in our cohort. In addition, our 5-year RFS for stage IIB (45%) and IIC (38%) were lower than the rates reported by Lee et al.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr24-10732748211053567" rid="bibr24-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">24</a>
</sup> in a survival analysis of stage II cutaneous melanoma (62 and 53%, respectively). Although we found that many of the first sites of recurrence were in transit/satellite in stage IIB (21%) and IIC (46%) patients, we do not have data on subsequent sites of tumor spread, and it is likely that many of these patients initially presented with locoregional recurrences and later developed distant metastases, contributing to poor survival rates. This underscores that, in the absence of nodal disease, higher T category is associated with worse outcomes in ALM, especially given that Breslow thickness was found to be a prognostic factor on the multivariable model. Due to the aforementioned unique molecular and genetic characteristics of ALM, it has been postulated that these tumors may present with more aggressive vertical growth phases,<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567" rid="bibr3-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567" rid="bibr13-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> as supported by the high median tumor thickness of 1.7&nbsp;mm in this cohort. Thus, stage IIB and IIC may have locally invasive tumors with high metastatic potential.</p><p>These recurrence patterns should be considered when tailoring surveillance strategies for ALM, particularly for patients who are stage IIB and higher. Current recommendations for melanoma follow-up are limited by a lack of prospective, randomized trials, resulting in surveillance strategies that vary widely.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr25-10732748211053567" rid="bibr25-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">25</a>
</sup> Guidelines for ALM-specific surveillance strategies are further limited by the low prevalence of this melanoma subtype. The NCCN guidelines for stages IIB-IV cutaneous melanoma recommend a history and physical exam with emphasis on the skin and lymph nodes every 3–6&nbsp;months for 2&nbsp;years, then every 3–12&nbsp;months for 3&nbsp;years, then annually.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr15-10732748211053567" rid="bibr15-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">15</a>
</sup> In one of the few prospective studies on melanoma surveillance, Garbe found that almost 50% of stage II and III recurrences were detected by clinical exam.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr26-10732748211053567" rid="bibr26-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">26</a>
</sup> Given that the most common first site of recurrence for stage IIC (48%), IIIB (78%), and IIIC (33%) patients in our cohort was satellite/in-transit, our findings further support the importance of the clinical exam in stage II and III ALM patients. The NCCN guidelines also recommend considering imaging for up to 5&nbsp;years to screen for recurrence and metastases for patients with stage IIB-IV cutaneous melanoma.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr15-10732748211053567" rid="bibr15-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">15</a>
</sup> For stage IIB ALM patients, examination and imaging of the lymph nodes may be particularly important given that 53% of patients with recurrence presented with regional nodal metastasis in our cohort. In addition, a majority of recurrences in stage IIB and higher occurred within 5&nbsp;years (95% for stage IIB, 100% for stage IIC, and 95% for stage III), suggesting that the timeline recommended by the NCCN for radiologic follow-up of cutaneous melanoma patients is appropriate for ALM as well.</p><p>These recurrence and survival patterns should also be taken into account when determining the need for adjuvant therapy. Immunotherapy has been shown to improve progression-free survival and overall survival in patients with metastatic melanoma.<sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr27-10732748211053567" rid="bibr27-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">27</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr28-10732748211053567" rid="bibr28-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">28</a></sup> While 41% of all patients in our cohort were treated prior to availability of currently utilized immunotherapies, many of the stage III and IV patients would be considered for immunotherapy if treated in the present. However, these therapies would not be indicated for stage II patients even if they were treated today. Given the worse 5-year MSS and RFS in stage IIB/IIC patients compared to stage IIIB, ALM patients may especially benefit from current clinical trials investigating the survival benefit of immunotherapy and targeted therapy in stage II disease (KEYNOTE-716).<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr28-10732748211053567" rid="bibr28-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">28</a>
</sup> Furthermore, given that ALM patients are often underrepresented in clinical trials and may respond to immunotherapy differently than other cutaneous melanomas, it is important that they be included in current and future trials.<sup>
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr29-10732748211053567" rid="bibr29-10732748211053567" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">29</a>
</sup></p><p class="p p-last">Because this study is a retrospective review of prospectively collected data, it is limited by not having full data on other variables that may impact recurrence and survival, such as socioeconomic factors, time between lesion onset and presentation, and date of diagnosis. We also did not have full data on the frequency and types of surveillance imaging utilized, which could help further inform surveillance strategies. In addition, 47.8% of patients were lost to follow-up prior to the date of final data collection, resulting in a median time to follow up of only 32&nbsp;months, and thus, our Kaplan–Meier estimates may underestimate the long-term risk of recurrence and death. In addition, the majority of our cohort was white, which may limit the applicability of these findings in non-white patients. Finally, because we are comparing our survival data to the much larger AJCC dataset, there is a chance of type I error; however, given the rarity of this subtype, it is unavoidable.</p></div><div id="sec14-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec14-10732748211053567title">Conclusion</h2><p class="p p-first-last">We present a large multi-center substage survival analysis of primary ALM patients. Patients with early stage disease (i.e., stage II patients) were associated with poor outcomes, consistent with prior cohort studies. The particularly low RFS and MSS rates in stage IIB/IIC patients compared to stage IIIB disease suggests that increased thickness is associated with worse outcomes, even in the absence of nodal metastases, and highlights that studies investigating adjuvant therapies in stage II cutaneous melanoma patients may be particularly valuable for ALM. Furthermore, the timing and sites of recurrence support the utilization of current cutaneous melanoma surveillance strategies for ALM patients.</p></div><div id="app1-10732748211053567" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="app1-10732748211053567title">Appendix A. </h2><!--/article/back/app-group/app/--><div class="def-list"><dl class="labeled-list"><dt id="G1-10732748211053567">AJCC</dt><dd>American Joint Cancer Committee</dd><dt id="G2-10732748211053567">ALM</dt><dd>acral lentiginous melanoma</dd><dt id="G3-10732748211053567">MSS</dt><dd>melanoma-specific survival</dd><dt id="G4-10732748211053567">NCCN</dt><dd>National Comprehensive Cancer Network</dd><dt id="G5-10732748211053567">RFS</dt><dd>recurrence-free survival</dd><dt id="G6-10732748211053567">SEER</dt><dd>Surveillance, Epidemiology, and End Results</dd><dt id="G7-10732748211053567">SLNB</dt><dd>sentinel lymph node biopsy</dd><dt id="G8-10732748211053567">UV</dt><dd>ultra-violet;</dd></dl></div></div><div id="fn-group-a.u.a" class="tsec sec"><h2 class="headless nomenu"></h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.u.a.a"></p><p class="p p-first-last"><strong>Declaration of Conflicting Interests:</strong> The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p><p></p><p class="fn sec" id="fn-a.u.a.b"></p><p class="p p-first-last"><strong>Funding:</strong> The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The NYU Langone Health melanoma database is supported in part by a Melanoma SPORE grant (P50 CA225450). The authors otherwise received no other financial support for the research, authorship, and/or publication of this article.</p><p></p></div></div><div id="fn-group-a.u.b" class="tsec sec"><h2 class="headless nomenu"></h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.u.b.a"></p><p class="p p-first-last"><strong>Ethical approval:</strong> This Study and waiver of consent were Approved by the respective institutional review boards of All collaborating institutions (NYU Langone, Moffitt Cancer Center, Emory University, Oregon Health &amp; Science University, University of Alabama Birmingham, and Duke University, Emory IRB#00101435).</p><p></p></div></div><div id="sec15-10732748211053567" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec15-10732748211053567title">ORCID iDs</h2><!--/article/back/sec/--><p class="p p-first">Avani M. Kolla <a href="https://orcid.org/0000-0002-4071-6092" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://orcid.org/0000-0002-4071-6092</a></p><p>Gerardo A. Vitiello <a href="https://orcid.org/0000-0002-7452-8903" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://orcid.org/0000-0002-7452-8903</a></p><p>Marvi Tariq <a href="https://orcid.org/0000-0001-5286-495X" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://orcid.org/0000-0001-5286-495X</a></p><p class="p p-last">Ann Lee <a href="https://orcid.org/0000-0002-8143-2635" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://orcid.org/0000-0002-8143-2635</a></p></div><div id="ref-list-a.u.d" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="ref-list-a.u.dtitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bibr1-10732748211053567">1. <span class="mixed-citation">Bradford PT, Goldstein AM, McMaster ML, Tucker MA. <span class="ref-title">Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986-2005</span>. <span class="ref-journal">Arch Dermatol</span>. 2009;<span class="ref-vol">145</span>(<span class="ref-iss">4</span>):427-434. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735055/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19380664" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Acral+lentiginous+melanoma:+Incidence+and+survival+patterns+in+the+United+States,+1986-2005&amp;author=PT+Bradford&amp;author=AM+Goldstein&amp;author=ML+McMaster&amp;author=MA+Tucker&amp;volume=145&amp;issue=4&amp;publication_year=2009&amp;pages=427-434&amp;pmid=19380664&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr2-10732748211053567">2. <span class="mixed-citation">Puccio FB, Chian C. <span class="ref-title">Acral junctional nevus versus acral lentiginous melanoma <em>in situ</em>: A differential diagnosis that should be based on clinicopathologic correlation</span>. <span class="ref-journal">Arch Pathol Lab Med</span>. 2011;<span class="ref-vol">135</span>(<span class="ref-iss">7</span>):847-852. [<a href="https://pubmed.ncbi.nlm.nih.gov/21732773" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Pathol+Lab+Med&amp;title=Acral+junctional+nevus+versus+acral+lentiginous+melanoma+in+situ:+A+differential+diagnosis+that+should+be+based+on+clinicopathologic+correlation&amp;author=FB+Puccio&amp;author=C+Chian&amp;volume=135&amp;issue=7&amp;publication_year=2011&amp;pages=847-852&amp;pmid=21732773&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr3-10732748211053567">3. <span class="mixed-citation">Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L. <span class="ref-title">Acral lentiginous melanoma: A clinicoprognostic study of 126 cases</span>. <span class="ref-journal">Br J Dermatol</span>. 2006;<span class="ref-vol">155</span>(<span class="ref-iss">3</span>):561-569. [<a href="https://pubmed.ncbi.nlm.nih.gov/16911282" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+lentiginous+melanoma:+A+clinicoprognostic+study+of+126+cases&amp;author=A+Phan&amp;author=S+Touzet&amp;author=S+Dalle&amp;author=S+Ronger-Savl%C3%A9&amp;author=B+Balme&amp;volume=155&amp;issue=3&amp;publication_year=2006&amp;pages=561-569&amp;pmid=16911282&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr4-10732748211053567">4. <span class="mixed-citation">Fujisawa Y, Yoshikawa S, Minagawa A, et al. <span class="ref-title">Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma</span>. <span class="ref-journal">Cancer Med</span>. 2019;<span class="ref-vol">8</span>(<span class="ref-iss">5</span>):2146-2156. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536943/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30932370" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Med&amp;title=Clinical+and+histopathological+characteristics+and+survival+analysis+of+4594+Japanese+patients+with+melanoma&amp;author=Y+Fujisawa&amp;author=S+Yoshikawa&amp;author=A+Minagawa&amp;volume=8&amp;issue=5&amp;publication_year=2019&amp;pages=2146-2156&amp;pmid=30932370&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr5-10732748211053567">5. <span class="mixed-citation">Huang K, Fan J, Misra S. <span class="ref-title">Acral lentiginous melanoma: Incidence and survival in the United States, 2006-2015, an analysis of the SEER registry</span>. <span class="ref-journal">J Surg Res</span>. 2020;<span class="ref-vol">251</span>:329-339. [<a href="https://pubmed.ncbi.nlm.nih.gov/32208196" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Surg+Res&amp;title=Acral+lentiginous+melanoma:+Incidence+and+survival+in+the+United+States,+2006-2015,+an+analysis+of+the+SEER+registry&amp;author=K+Huang&amp;author=J+Fan&amp;author=S+Misra&amp;volume=251&amp;publication_year=2020&amp;pages=329-339&amp;pmid=32208196&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr6-10732748211053567">6. <span class="mixed-citation">Teramoto Y, Keim U, Gesierich A, et al. <span class="ref-title">Acral lentiginous melanoma: A skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients</span>. <span class="ref-journal">Br J Dermatol</span>. 2018;<span class="ref-vol">178</span>(<span class="ref-iss">2</span>):443-451. [<a href="https://pubmed.ncbi.nlm.nih.gov/28707317" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+lentiginous+melanoma:+A+skin+cancer+with+unfavourable+prognostic+features.+A+study+of+the+German+central+malignant+melanoma+registry+(CMMR)+in+2050+patients&amp;author=Y+Teramoto&amp;author=U+Keim&amp;author=A+Gesierich&amp;volume=178&amp;issue=2&amp;publication_year=2018&amp;pages=443-451&amp;pmid=28707317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr7-10732748211053567">7. <span class="mixed-citation">Wada M, Ito T, Tsuji G, et al. <span class="ref-title">Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan</span>. <span class="ref-journal">J Dermatol</span>. 2017;<span class="ref-vol">44</span>(<span class="ref-iss">8</span>):932-938. [<a href="https://pubmed.ncbi.nlm.nih.gov/28342269" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Dermatol&amp;title=Acral+lentiginous+melanoma+versus+other+melanoma:+A+single-center+analysis+in+Japan&amp;author=M+Wada&amp;author=T+Ito&amp;author=G+Tsuji&amp;volume=44&amp;issue=8&amp;publication_year=2017&amp;pages=932-938&amp;pmid=28342269&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr8-10732748211053567">8. <span class="mixed-citation">Carrera C, Gual A, Díaz A, et al. <span class="ref-title">Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians</span>. <span class="ref-journal">Melanoma Research</span>. 2017;<span class="ref-vol">27</span>(<span class="ref-iss">4</span>):315-320. [<a href="https://pubmed.ncbi.nlm.nih.gov/28296711" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Melanoma+Research&amp;title=Prognostic+role+of+the+histological+subtype+of+melanoma+on+the+hands+and+feet+in+Caucasians&amp;author=C+Carrera&amp;author=A+Gual&amp;author=A+D%C3%ADaz&amp;volume=27&amp;issue=4&amp;publication_year=2017&amp;pages=315-320&amp;pmid=28296711&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr9-10732748211053567">9. <span class="mixed-citation">Duarte CA, Flórez JP, López HG, Meneses MX, de Vries E. <span class="ref-title">Survival of acral lentiginous melanoma in the national cancer institute of Colombia</span>. <span class="ref-journal">JEADV</span>. 2017;<span class="ref-vol">31</span>(<span class="ref-iss">3</span>):438-442. [<a href="https://pubmed.ncbi.nlm.nih.gov/27518480" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JEADV&amp;title=Survival+of+acral+lentiginous+melanoma+in+the+national+cancer+institute+of+Colombia&amp;author=CA+Duarte&amp;author=JP+Fl%C3%B3rez&amp;author=HG+L%C3%B3pez&amp;author=MX+Meneses&amp;author=E+de+Vries&amp;volume=31&amp;issue=3&amp;publication_year=2017&amp;pages=438-442&amp;pmid=27518480&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr10-10732748211053567">10. <span class="mixed-citation">Kato T, Suetake T, Tabata N, Takahashi K, Tagami H. <span class="ref-title">Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period</span>. <span class="ref-journal">Int J Dermatol</span>. 1999;<span class="ref-vol">38</span>(<span class="ref-iss">7</span>):515-519. [<a href="https://pubmed.ncbi.nlm.nih.gov/10440280" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Dermatol&amp;title=Epidemiology+and+prognosis+of+plantar+melanoma+in+62+Japanese+patients+over+a+28-year+period&amp;author=T+Kato&amp;author=T+Suetake&amp;author=N+Tabata&amp;author=K+Takahashi&amp;author=H+Tagami&amp;volume=38&amp;issue=7&amp;publication_year=1999&amp;pages=515-519&amp;pmid=10440280&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr11-10732748211053567">11. <span class="mixed-citation">Kuchelmeister C, Schaumburg-Lever G, Garbe C. <span class="ref-title">Acral cutaneous melanoma in caucasians: Clinical features, histopathology and prognosis in 112 patients</span>. <span class="ref-journal">Br J Dermatol</span>. 2000;<span class="ref-vol">143</span>(<span class="ref-iss">2</span>):275-280. [<a href="https://pubmed.ncbi.nlm.nih.gov/10951133" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+cutaneous+melanoma+in+caucasians:+Clinical+features,+histopathology+and+prognosis+in+112+patients&amp;author=C+Kuchelmeister&amp;author=G+Schaumburg-Lever&amp;author=C+Garbe&amp;volume=143&amp;issue=2&amp;publication_year=2000&amp;pages=275-280&amp;pmid=10951133&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr12-10732748211053567">12. <span class="mixed-citation">Reyes E, Uribe C, de Vries E. <span class="ref-title">Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009</span>. <span class="ref-journal">Int J Dermatol</span>. 2018;<span class="ref-vol">57</span>(<span class="ref-iss">1</span>):21-27. [<a href="https://pubmed.ncbi.nlm.nih.gov/29231241" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Dermatol&amp;title=Population-based+incidence+and+melanoma-specific+survival+of+cutaneous+malignant+melanoma+in+a+Colombian+population+2000-2009&amp;author=E+Reyes&amp;author=C+Uribe&amp;author=E+de+Vries&amp;volume=57&amp;issue=1&amp;publication_year=2018&amp;pages=21-27&amp;pmid=29231241&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr13-10732748211053567">13. <span class="mixed-citation">Bello DM, Chou JF, Panageas KS, et al. <span class="ref-title">Prognosis of acral melanoma: A series of 281 patients</span>. <span class="ref-journal">Ann Surg Oncol</span>. 2013;<span class="ref-vol">20</span>(<span class="ref-iss">11</span>):3618-3625. [<a href="https://pubmed.ncbi.nlm.nih.gov/23838913" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=Prognosis+of+acral+melanoma:+A+series+of+281+patients&amp;author=DM+Bello&amp;author=JF+Chou&amp;author=KS+Panageas&amp;volume=20&amp;issue=11&amp;publication_year=2013&amp;pages=3618-3625&amp;pmid=23838913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr14-10732748211053567">14. <span class="mixed-citation">Liang WS, Hendricks W, Kiefer J, et al. <span class="ref-title">Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma</span>. <span class="ref-journal">Genome Research</span>. 2017;<span class="ref-vol">27</span>(<span class="ref-iss">4</span>):524-532. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378171/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28373299" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Research&amp;title=Integrated+genomic+analyses+reveal+frequent+TERT+aberrations+in+acral+melanoma&amp;author=WS+Liang&amp;author=W+Hendricks&amp;author=J+Kiefer&amp;volume=27&amp;issue=4&amp;publication_year=2017&amp;pages=524-532&amp;pmid=28373299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr15-10732748211053567">15. <span class="mixed-citation">Coit DG, Thompson JA, Albertini MR, et al. <span class="ref-title">Cutaneous melanoma, version 2.2019, NCCN Clinical Practice Guidelines in Oncology</span>. <span class="ref-journal">J Natl Compr Canc Netw</span>. 2019;<span class="ref-vol">17</span>(<span class="ref-iss">4</span>):367. [<a href="https://pubmed.ncbi.nlm.nih.gov/30959471" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Compr+Canc+Netw&amp;title=Cutaneous+melanoma,+version+2.2019,+NCCN+Clinical+Practice+Guidelines+in+Oncology&amp;author=DG+Coit&amp;author=JA+Thompson&amp;author=MR+Albertini&amp;volume=17&amp;issue=4&amp;publication_year=2019&amp;pages=367&amp;pmid=30959471&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr16-10732748211053567">16. <span class="mixed-citation">Gershenwald JE, Scolyer RA, Hess KR, et al. <span class="ref-title">Melanoma staging: Evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual</span>. <span class="ref-journal">CA Cancer J Clin</span>. 2017;<span class="ref-vol">67</span>(<span class="ref-iss">6</span>):472-492. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978683/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29028110" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;title=Melanoma+staging:+Evidence-based+changes+in+the+American+joint+committee+on+cancer+eighth+edition+cancer+staging+manual&amp;author=JE+Gershenwald&amp;author=RA+Scolyer&amp;author=KR+Hess&amp;volume=67&amp;issue=6&amp;publication_year=2017&amp;pages=472-492&amp;pmid=29028110&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr17-10732748211053567">17. <span class="mixed-citation">Carrera C, Scope A, Dusza SW, et al. <span class="ref-title">Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases</span>. <span class="ref-journal">J Am Acad Dermatol</span>. 2018;<span class="ref-vol">78</span>(<span class="ref-iss">2</span>):278-288. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344877/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29024734" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Clinical+and+dermoscopic+characterization+of+pediatric+and+adolescent+melanomas:+Multicenter+study+of+52+cases&amp;author=C+Carrera&amp;author=A+Scope&amp;author=SW+Dusza&amp;volume=78&amp;issue=2&amp;publication_year=2018&amp;pages=278-288&amp;pmid=29024734&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr18-10732748211053567">18. <span class="mixed-citation">Curtin JA, Fridlyand J, Kageshita T, et al. <span class="ref-title">Distinct sets of genetic alterations in melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2005;<span class="ref-vol">353</span>(<span class="ref-iss">20</span>):2135-2147. [<a href="https://pubmed.ncbi.nlm.nih.gov/16291983" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Distinct+sets+of+genetic+alterations+in+melanoma&amp;author=JA+Curtin&amp;author=J+Fridlyand&amp;author=T+Kageshita&amp;volume=353&amp;issue=20&amp;publication_year=2005&amp;pages=2135-2147&amp;pmid=16291983&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr19-10732748211053567">19. <span class="mixed-citation">Haugh AM, Zhang B, Quan VL, et al. <span class="ref-title">Distinct patterns of acral melanoma based on site and relative sun exposure</span>. <span class="ref-journal">J Invest Dermatol</span>. 2018;<span class="ref-vol">138</span>(<span class="ref-iss">2</span>):384-393. [<a href="https://pubmed.ncbi.nlm.nih.gov/28870692" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Distinct+patterns+of+acral+melanoma+based+on+site+and+relative+sun+exposure&amp;author=AM+Haugh&amp;author=B+Zhang&amp;author=VL+Quan&amp;volume=138&amp;issue=2&amp;publication_year=2018&amp;pages=384-393&amp;pmid=28870692&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr20-10732748211053567">20. <span class="mixed-citation">Hayward NK, Wilmott JS, Waddell N, et al. <span class="ref-title">Whole-genome landscapes of major melanoma subtypes</span>. <span class="ref-journal">Nature</span>. 2017;<span class="ref-vol">545</span>(<span class="ref-iss">7653</span>):175-180. [<a href="https://pubmed.ncbi.nlm.nih.gov/28467829" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Whole-genome+landscapes+of+major+melanoma+subtypes&amp;author=NK+Hayward&amp;author=JS+Wilmott&amp;author=N+Waddell&amp;volume=545&amp;issue=7653&amp;publication_year=2017&amp;pages=175-180&amp;pmid=28467829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr21-10732748211053567">21. <span class="mixed-citation">Curtin JA, Busam K, Pinkel D, Bastian BC. <span class="ref-title">Somatic activation of KIT in distinct subtypes of melanoma</span>. <span class="ref-journal">J Clin Oncol</span>. 2006;<span class="ref-vol">24</span>(<span class="ref-iss">26</span>):4340-4346. [<a href="https://pubmed.ncbi.nlm.nih.gov/16908931" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Somatic+activation+of+KIT+in+distinct+subtypes+of+melanoma&amp;author=JA+Curtin&amp;author=K+Busam&amp;author=D+Pinkel&amp;author=BC+Bastian&amp;volume=24&amp;issue=26&amp;publication_year=2006&amp;pages=4340-4346&amp;pmid=16908931&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr22-10732748211053567">22. <span class="mixed-citation">Cormier JN, Xing Y, Ding M, et al. <span class="ref-title">Ethnic differences among patients with cutaneous melanoma</span>. <span class="ref-journal">Arch Intern Med</span>. 2006;<span class="ref-vol">166</span>(<span class="ref-iss">17</span>):1907-1914. [<a href="https://pubmed.ncbi.nlm.nih.gov/17000949" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Ethnic+differences+among+patients+with+cutaneous+melanoma&amp;author=JN+Cormier&amp;author=Y+Xing&amp;author=M+Ding&amp;volume=166&amp;issue=17&amp;publication_year=2006&amp;pages=1907-1914&amp;pmid=17000949&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr23-10732748211053567">23. <span class="mixed-citation">Lee AY, Droppelmann N, Panageas KS, et al. <span class="ref-title">Patterns and timing of initial relapse in pathologic stage II melanoma patients</span>. <span class="ref-journal">Ann Surg Oncol</span>. 2017;<span class="ref-vol">24</span>(<span class="ref-iss">4</span>):939-946. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505631/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27804026" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=Patterns+and+timing+of+initial+relapse+in+pathologic+stage+II+melanoma+patients&amp;author=AY+Lee&amp;author=N+Droppelmann&amp;author=KS+Panageas&amp;volume=24&amp;issue=4&amp;publication_year=2017&amp;pages=939-946&amp;pmid=27804026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr24-10732748211053567">24. <span class="mixed-citation">Rueth NM, Xing Y, Chiang Y-J, et al. <span class="ref-title">Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies</span>. <span class="ref-journal">Ann Surg</span>. 2014;<span class="ref-vol">259</span>(<span class="ref-iss">6</span>):1215-1222. [<a href="https://pubmed.ncbi.nlm.nih.gov/24096759" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Is+surveillance+imaging+effective+for+detecting+surgically+treatable+recurrences+in+patients+with+melanoma?+A+comparative+analysis+of+stage-specific+surveillance+strategies&amp;author=NM+Rueth&amp;author=Y+Xing&amp;author=Y-J+Chiang&amp;volume=259&amp;issue=6&amp;publication_year=2014&amp;pages=1215-1222&amp;pmid=24096759&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr25-10732748211053567">25. <span class="mixed-citation">Garbe C, Paul A, Kohler-Späth H, et al. <span class="ref-title">Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy</span>. <span class="ref-journal">J Clin Oncol</span>. 2003;<span class="ref-vol">21</span>(<span class="ref-iss">3</span>):520-529. [<a href="https://pubmed.ncbi.nlm.nih.gov/12560444" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Prospective+evaluation+of+a+follow-up+schedule+in+cutaneous+melanoma+patients:+Recommendations+for+an+effective+follow-up+strategy&amp;author=C+Garbe&amp;author=A+Paul&amp;author=H+Kohler-Sp%C3%A4th&amp;volume=21&amp;issue=3&amp;publication_year=2003&amp;pages=520-529&amp;pmid=12560444&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr26-10732748211053567">26. <span class="mixed-citation">Larkin J, Chiarion-Sileni V, Gonzalez R, et al. <span class="ref-title">Combined nivolumab and ipilimumab or monotherapy in untreated melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2015;<span class="ref-vol">373</span>(<span class="ref-iss">1</span>):23-34. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698905/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26027431" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Combined+nivolumab+and+ipilimumab+or+monotherapy+in+untreated+melanoma&amp;author=J+Larkin&amp;author=V+Chiarion-Sileni&amp;author=R+Gonzalez&amp;volume=373&amp;issue=1&amp;publication_year=2015&amp;pages=23-34&amp;pmid=26027431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr27-10732748211053567">27. <span class="mixed-citation">Hodi FS, O’Day SJ, McDermott DF, et al. <span class="ref-title">Improved survival with ipilimumab in patients with metastatic melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2010;<span class="ref-vol">363</span>(<span class="ref-iss">8</span>):711-723. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549297/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20525992" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Improved+survival+with+ipilimumab+in+patients+with+metastatic+melanoma&amp;author=FS+Hodi&amp;author=SJ+O%E2%80%99Day&amp;author=DF+McDermott&amp;volume=363&amp;issue=8&amp;publication_year=2010&amp;pages=711-723&amp;pmid=20525992&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr28-10732748211053567">28. <span class="mixed-citation">Luke JJ, Ascierto PA, Carlino MS, et al. <span class="ref-title">KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma</span>. <span class="ref-journal">Future Oncol</span>. 2020;<span class="ref-vol">16</span>(<span class="ref-iss">3</span>):4429-4438. [<a href="https://pubmed.ncbi.nlm.nih.gov/31870188" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Future+Oncol&amp;title=KEYNOTE-716:+Phase+III+study+of+adjuvant+pembrolizumab+versus+placebo+in+resected+high-risk+stage+II+melanoma&amp;author=JJ+Luke&amp;author=PA+Ascierto&amp;author=MS+Carlino&amp;volume=16&amp;issue=3&amp;publication_year=2020&amp;pages=4429-4438&amp;pmid=31870188&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bibr29-10732748211053567">29. <span class="mixed-citation">Nakamura Y, Namikawa K, Yoshino K, et al. <span class="ref-title">Anti-PD1 checkpoint inhibitor therapy in acral melanoma: A multicenter study of 193 Japanese patients</span>. <span class="ref-journal">Ann Oncol</span>. 2020;<span class="ref-vol">31</span>(<span class="ref-iss">9</span>):1198-1206. [<a href="https://pubmed.ncbi.nlm.nih.gov/32522691" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Anti-PD1+checkpoint+inhibitor+therapy+in+acral+melanoma:+A+multicenter+study+of+193+Japanese+patients&amp;author=Y+Nakamura&amp;author=K+Namikawa&amp;author=K+Yoshino&amp;volume=31&amp;issue=9&amp;publication_year=2020&amp;pages=1198-1206&amp;pmid=32522691&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#abstract-a.s.b.mtitle">Abstract</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec6-10732748211053567title">Introduction</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec7-10732748211053567title">Methods</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec8-10732748211053567title">Results</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec13-10732748211053567title">Discussion</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec14-10732748211053567title">Conclusion</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#app1-10732748211053567title">Appendix A. </a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#sec15-10732748211053567title">ORCID iDs</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#ref-list-a.u.dtitle">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Cancer Control : Journal of the Moffitt Cancer Center</span> are provided here courtesy of <strong>SAGE Publications</strong></div><hr></div><div id="body-link-poppers"><span></span><div id="body-link-popper-bibr1-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">1. <span class="mixed-citation">Bradford PT, Goldstein AM, McMaster ML, Tucker MA. <span class="ref-title">Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986-2005</span>. <span class="ref-journal">Arch Dermatol</span>. 2009;<span class="ref-vol">145</span>(<span class="ref-iss">4</span>):427-434. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735055/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19380664" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Acral+lentiginous+melanoma:+Incidence+and+survival+patterns+in+the+United+States,+1986-2005&amp;author=PT+Bradford&amp;author=AM+Goldstein&amp;author=ML+McMaster&amp;author=MA+Tucker&amp;volume=145&amp;issue=4&amp;publication_year=2009&amp;pages=427-434&amp;pmid=19380664&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr1-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr2-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 400px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">2. <span class="mixed-citation">Puccio FB, Chian C. <span class="ref-title">Acral junctional nevus versus acral lentiginous melanoma <em>in situ</em>: A differential diagnosis that should be based on clinicopathologic correlation</span>. <span class="ref-journal">Arch Pathol Lab Med</span>. 2011;<span class="ref-vol">135</span>(<span class="ref-iss">7</span>):847-852. [<a href="https://pubmed.ncbi.nlm.nih.gov/21732773" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Pathol+Lab+Med&amp;title=Acral+junctional+nevus+versus+acral+lentiginous+melanoma+in+situ:+A+differential+diagnosis+that+should+be+based+on+clinicopathologic+correlation&amp;author=FB+Puccio&amp;author=C+Chian&amp;volume=135&amp;issue=7&amp;publication_year=2011&amp;pages=847-852&amp;pmid=21732773&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr2-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr3-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">3. <span class="mixed-citation">Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L. <span class="ref-title">Acral lentiginous melanoma: A clinicoprognostic study of 126 cases</span>. <span class="ref-journal">Br J Dermatol</span>. 2006;<span class="ref-vol">155</span>(<span class="ref-iss">3</span>):561-569. [<a href="https://pubmed.ncbi.nlm.nih.gov/16911282" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+lentiginous+melanoma:+A+clinicoprognostic+study+of+126+cases&amp;author=A+Phan&amp;author=S+Touzet&amp;author=S+Dalle&amp;author=S+Ronger-Savl%C3%A9&amp;author=B+Balme&amp;volume=155&amp;issue=3&amp;publication_year=2006&amp;pages=561-569&amp;pmid=16911282&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr3-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr4-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 400px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">4. <span class="mixed-citation">Fujisawa Y, Yoshikawa S, Minagawa A, et al. <span class="ref-title">Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma</span>. <span class="ref-journal">Cancer Med</span>. 2019;<span class="ref-vol">8</span>(<span class="ref-iss">5</span>):2146-2156. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536943/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30932370" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Med&amp;title=Clinical+and+histopathological+characteristics+and+survival+analysis+of+4594+Japanese+patients+with+melanoma&amp;author=Y+Fujisawa&amp;author=S+Yoshikawa&amp;author=A+Minagawa&amp;volume=8&amp;issue=5&amp;publication_year=2019&amp;pages=2146-2156&amp;pmid=30932370&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr4-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr5-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">5. <span class="mixed-citation">Huang K, Fan J, Misra S. <span class="ref-title">Acral lentiginous melanoma: Incidence and survival in the United States, 2006-2015, an analysis of the SEER registry</span>. <span class="ref-journal">J Surg Res</span>. 2020;<span class="ref-vol">251</span>:329-339. [<a href="https://pubmed.ncbi.nlm.nih.gov/32208196" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Surg+Res&amp;title=Acral+lentiginous+melanoma:+Incidence+and+survival+in+the+United+States,+2006-2015,+an+analysis+of+the+SEER+registry&amp;author=K+Huang&amp;author=J+Fan&amp;author=S+Misra&amp;volume=251&amp;publication_year=2020&amp;pages=329-339&amp;pmid=32208196&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr5-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr6-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">6. <span class="mixed-citation">Teramoto Y, Keim U, Gesierich A, et al. <span class="ref-title">Acral lentiginous melanoma: A skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients</span>. <span class="ref-journal">Br J Dermatol</span>. 2018;<span class="ref-vol">178</span>(<span class="ref-iss">2</span>):443-451. [<a href="https://pubmed.ncbi.nlm.nih.gov/28707317" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+lentiginous+melanoma:+A+skin+cancer+with+unfavourable+prognostic+features.+A+study+of+the+German+central+malignant+melanoma+registry+(CMMR)+in+2050+patients&amp;author=Y+Teramoto&amp;author=U+Keim&amp;author=A+Gesierich&amp;volume=178&amp;issue=2&amp;publication_year=2018&amp;pages=443-451&amp;pmid=28707317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr6-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr7-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">7. <span class="mixed-citation">Wada M, Ito T, Tsuji G, et al. <span class="ref-title">Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan</span>. <span class="ref-journal">J Dermatol</span>. 2017;<span class="ref-vol">44</span>(<span class="ref-iss">8</span>):932-938. [<a href="https://pubmed.ncbi.nlm.nih.gov/28342269" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Dermatol&amp;title=Acral+lentiginous+melanoma+versus+other+melanoma:+A+single-center+analysis+in+Japan&amp;author=M+Wada&amp;author=T+Ito&amp;author=G+Tsuji&amp;volume=44&amp;issue=8&amp;publication_year=2017&amp;pages=932-938&amp;pmid=28342269&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr7-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr8-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">8. <span class="mixed-citation">Carrera C, Gual A, Díaz A, et al. <span class="ref-title">Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians</span>. <span class="ref-journal">Melanoma Research</span>. 2017;<span class="ref-vol">27</span>(<span class="ref-iss">4</span>):315-320. [<a href="https://pubmed.ncbi.nlm.nih.gov/28296711" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Melanoma+Research&amp;title=Prognostic+role+of+the+histological+subtype+of+melanoma+on+the+hands+and+feet+in+Caucasians&amp;author=C+Carrera&amp;author=A+Gual&amp;author=A+D%C3%ADaz&amp;volume=27&amp;issue=4&amp;publication_year=2017&amp;pages=315-320&amp;pmid=28296711&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr8-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr9-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">9. <span class="mixed-citation">Duarte CA, Flórez JP, López HG, Meneses MX, de Vries E. <span class="ref-title">Survival of acral lentiginous melanoma in the national cancer institute of Colombia</span>. <span class="ref-journal">JEADV</span>. 2017;<span class="ref-vol">31</span>(<span class="ref-iss">3</span>):438-442. [<a href="https://pubmed.ncbi.nlm.nih.gov/27518480" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JEADV&amp;title=Survival+of+acral+lentiginous+melanoma+in+the+national+cancer+institute+of+Colombia&amp;author=CA+Duarte&amp;author=JP+Fl%C3%B3rez&amp;author=HG+L%C3%B3pez&amp;author=MX+Meneses&amp;author=E+de+Vries&amp;volume=31&amp;issue=3&amp;publication_year=2017&amp;pages=438-442&amp;pmid=27518480&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr9-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr10-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">10. <span class="mixed-citation">Kato T, Suetake T, Tabata N, Takahashi K, Tagami H. <span class="ref-title">Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period</span>. <span class="ref-journal">Int J Dermatol</span>. 1999;<span class="ref-vol">38</span>(<span class="ref-iss">7</span>):515-519. [<a href="https://pubmed.ncbi.nlm.nih.gov/10440280" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Dermatol&amp;title=Epidemiology+and+prognosis+of+plantar+melanoma+in+62+Japanese+patients+over+a+28-year+period&amp;author=T+Kato&amp;author=T+Suetake&amp;author=N+Tabata&amp;author=K+Takahashi&amp;author=H+Tagami&amp;volume=38&amp;issue=7&amp;publication_year=1999&amp;pages=515-519&amp;pmid=10440280&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr10-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr11-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">11. <span class="mixed-citation">Kuchelmeister C, Schaumburg-Lever G, Garbe C. <span class="ref-title">Acral cutaneous melanoma in caucasians: Clinical features, histopathology and prognosis in 112 patients</span>. <span class="ref-journal">Br J Dermatol</span>. 2000;<span class="ref-vol">143</span>(<span class="ref-iss">2</span>):275-280. [<a href="https://pubmed.ncbi.nlm.nih.gov/10951133" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Dermatol&amp;title=Acral+cutaneous+melanoma+in+caucasians:+Clinical+features,+histopathology+and+prognosis+in+112+patients&amp;author=C+Kuchelmeister&amp;author=G+Schaumburg-Lever&amp;author=C+Garbe&amp;volume=143&amp;issue=2&amp;publication_year=2000&amp;pages=275-280&amp;pmid=10951133&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr11-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr12-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">12. <span class="mixed-citation">Reyes E, Uribe C, de Vries E. <span class="ref-title">Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009</span>. <span class="ref-journal">Int J Dermatol</span>. 2018;<span class="ref-vol">57</span>(<span class="ref-iss">1</span>):21-27. [<a href="https://pubmed.ncbi.nlm.nih.gov/29231241" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Dermatol&amp;title=Population-based+incidence+and+melanoma-specific+survival+of+cutaneous+malignant+melanoma+in+a+Colombian+population+2000-2009&amp;author=E+Reyes&amp;author=C+Uribe&amp;author=E+de+Vries&amp;volume=57&amp;issue=1&amp;publication_year=2018&amp;pages=21-27&amp;pmid=29231241&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr12-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr13-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">13. <span class="mixed-citation">Bello DM, Chou JF, Panageas KS, et al. <span class="ref-title">Prognosis of acral melanoma: A series of 281 patients</span>. <span class="ref-journal">Ann Surg Oncol</span>. 2013;<span class="ref-vol">20</span>(<span class="ref-iss">11</span>):3618-3625. [<a href="https://pubmed.ncbi.nlm.nih.gov/23838913" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=Prognosis+of+acral+melanoma:+A+series+of+281+patients&amp;author=DM+Bello&amp;author=JF+Chou&amp;author=KS+Panageas&amp;volume=20&amp;issue=11&amp;publication_year=2013&amp;pages=3618-3625&amp;pmid=23838913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr13-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr14-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 400px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">14. <span class="mixed-citation">Liang WS, Hendricks W, Kiefer J, et al. <span class="ref-title">Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma</span>. <span class="ref-journal">Genome Research</span>. 2017;<span class="ref-vol">27</span>(<span class="ref-iss">4</span>):524-532. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378171/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28373299" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Research&amp;title=Integrated+genomic+analyses+reveal+frequent+TERT+aberrations+in+acral+melanoma&amp;author=WS+Liang&amp;author=W+Hendricks&amp;author=J+Kiefer&amp;volume=27&amp;issue=4&amp;publication_year=2017&amp;pages=524-532&amp;pmid=28373299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr14-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr15-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">15. <span class="mixed-citation">Coit DG, Thompson JA, Albertini MR, et al. <span class="ref-title">Cutaneous melanoma, version 2.2019, NCCN Clinical Practice Guidelines in Oncology</span>. <span class="ref-journal">J Natl Compr Canc Netw</span>. 2019;<span class="ref-vol">17</span>(<span class="ref-iss">4</span>):367. [<a href="https://pubmed.ncbi.nlm.nih.gov/30959471" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Compr+Canc+Netw&amp;title=Cutaneous+melanoma,+version+2.2019,+NCCN+Clinical+Practice+Guidelines+in+Oncology&amp;author=DG+Coit&amp;author=JA+Thompson&amp;author=MR+Albertini&amp;volume=17&amp;issue=4&amp;publication_year=2019&amp;pages=367&amp;pmid=30959471&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr15-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr16-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">16. <span class="mixed-citation">Gershenwald JE, Scolyer RA, Hess KR, et al. <span class="ref-title">Melanoma staging: Evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual</span>. <span class="ref-journal">CA Cancer J Clin</span>. 2017;<span class="ref-vol">67</span>(<span class="ref-iss">6</span>):472-492. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978683/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29028110" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;title=Melanoma+staging:+Evidence-based+changes+in+the+American+joint+committee+on+cancer+eighth+edition+cancer+staging+manual&amp;author=JE+Gershenwald&amp;author=RA+Scolyer&amp;author=KR+Hess&amp;volume=67&amp;issue=6&amp;publication_year=2017&amp;pages=472-492&amp;pmid=29028110&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr16-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr17-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 400px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">17. <span class="mixed-citation">Carrera C, Scope A, Dusza SW, et al. <span class="ref-title">Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases</span>. <span class="ref-journal">J Am Acad Dermatol</span>. 2018;<span class="ref-vol">78</span>(<span class="ref-iss">2</span>):278-288. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344877/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29024734" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Clinical+and+dermoscopic+characterization+of+pediatric+and+adolescent+melanomas:+Multicenter+study+of+52+cases&amp;author=C+Carrera&amp;author=A+Scope&amp;author=SW+Dusza&amp;volume=78&amp;issue=2&amp;publication_year=2018&amp;pages=278-288&amp;pmid=29024734&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr17-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr18-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">18. <span class="mixed-citation">Curtin JA, Fridlyand J, Kageshita T, et al. <span class="ref-title">Distinct sets of genetic alterations in melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2005;<span class="ref-vol">353</span>(<span class="ref-iss">20</span>):2135-2147. [<a href="https://pubmed.ncbi.nlm.nih.gov/16291983" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Distinct+sets+of+genetic+alterations+in+melanoma&amp;author=JA+Curtin&amp;author=J+Fridlyand&amp;author=T+Kageshita&amp;volume=353&amp;issue=20&amp;publication_year=2005&amp;pages=2135-2147&amp;pmid=16291983&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr18-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr19-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">19. <span class="mixed-citation">Haugh AM, Zhang B, Quan VL, et al. <span class="ref-title">Distinct patterns of acral melanoma based on site and relative sun exposure</span>. <span class="ref-journal">J Invest Dermatol</span>. 2018;<span class="ref-vol">138</span>(<span class="ref-iss">2</span>):384-393. [<a href="https://pubmed.ncbi.nlm.nih.gov/28870692" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Distinct+patterns+of+acral+melanoma+based+on+site+and+relative+sun+exposure&amp;author=AM+Haugh&amp;author=B+Zhang&amp;author=VL+Quan&amp;volume=138&amp;issue=2&amp;publication_year=2018&amp;pages=384-393&amp;pmid=28870692&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr19-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr20-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">20. <span class="mixed-citation">Hayward NK, Wilmott JS, Waddell N, et al. <span class="ref-title">Whole-genome landscapes of major melanoma subtypes</span>. <span class="ref-journal">Nature</span>. 2017;<span class="ref-vol">545</span>(<span class="ref-iss">7653</span>):175-180. [<a href="https://pubmed.ncbi.nlm.nih.gov/28467829" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Whole-genome+landscapes+of+major+melanoma+subtypes&amp;author=NK+Hayward&amp;author=JS+Wilmott&amp;author=N+Waddell&amp;volume=545&amp;issue=7653&amp;publication_year=2017&amp;pages=175-180&amp;pmid=28467829&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr20-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr21-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">21. <span class="mixed-citation">Curtin JA, Busam K, Pinkel D, Bastian BC. <span class="ref-title">Somatic activation of KIT in distinct subtypes of melanoma</span>. <span class="ref-journal">J Clin Oncol</span>. 2006;<span class="ref-vol">24</span>(<span class="ref-iss">26</span>):4340-4346. [<a href="https://pubmed.ncbi.nlm.nih.gov/16908931" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Somatic+activation+of+KIT+in+distinct+subtypes+of+melanoma&amp;author=JA+Curtin&amp;author=K+Busam&amp;author=D+Pinkel&amp;author=BC+Bastian&amp;volume=24&amp;issue=26&amp;publication_year=2006&amp;pages=4340-4346&amp;pmid=16908931&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr21-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr22-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">22. <span class="mixed-citation">Cormier JN, Xing Y, Ding M, et al. <span class="ref-title">Ethnic differences among patients with cutaneous melanoma</span>. <span class="ref-journal">Arch Intern Med</span>. 2006;<span class="ref-vol">166</span>(<span class="ref-iss">17</span>):1907-1914. [<a href="https://pubmed.ncbi.nlm.nih.gov/17000949" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Ethnic+differences+among+patients+with+cutaneous+melanoma&amp;author=JN+Cormier&amp;author=Y+Xing&amp;author=M+Ding&amp;volume=166&amp;issue=17&amp;publication_year=2006&amp;pages=1907-1914&amp;pmid=17000949&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr22-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr23-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">23. <span class="mixed-citation">Lee AY, Droppelmann N, Panageas KS, et al. <span class="ref-title">Patterns and timing of initial relapse in pathologic stage II melanoma patients</span>. <span class="ref-journal">Ann Surg Oncol</span>. 2017;<span class="ref-vol">24</span>(<span class="ref-iss">4</span>):939-946. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505631/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27804026" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg+Oncol&amp;title=Patterns+and+timing+of+initial+relapse+in+pathologic+stage+II+melanoma+patients&amp;author=AY+Lee&amp;author=N+Droppelmann&amp;author=KS+Panageas&amp;volume=24&amp;issue=4&amp;publication_year=2017&amp;pages=939-946&amp;pmid=27804026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr23-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr24-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">24. <span class="mixed-citation">Rueth NM, Xing Y, Chiang Y-J, et al. <span class="ref-title">Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies</span>. <span class="ref-journal">Ann Surg</span>. 2014;<span class="ref-vol">259</span>(<span class="ref-iss">6</span>):1215-1222. [<a href="https://pubmed.ncbi.nlm.nih.gov/24096759" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Surg&amp;title=Is+surveillance+imaging+effective+for+detecting+surgically+treatable+recurrences+in+patients+with+melanoma?+A+comparative+analysis+of+stage-specific+surveillance+strategies&amp;author=NM+Rueth&amp;author=Y+Xing&amp;author=Y-J+Chiang&amp;volume=259&amp;issue=6&amp;publication_year=2014&amp;pages=1215-1222&amp;pmid=24096759&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr24-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr25-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">25. <span class="mixed-citation">Garbe C, Paul A, Kohler-Späth H, et al. <span class="ref-title">Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy</span>. <span class="ref-journal">J Clin Oncol</span>. 2003;<span class="ref-vol">21</span>(<span class="ref-iss">3</span>):520-529. [<a href="https://pubmed.ncbi.nlm.nih.gov/12560444" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Prospective+evaluation+of+a+follow-up+schedule+in+cutaneous+melanoma+patients:+Recommendations+for+an+effective+follow-up+strategy&amp;author=C+Garbe&amp;author=A+Paul&amp;author=H+Kohler-Sp%C3%A4th&amp;volume=21&amp;issue=3&amp;publication_year=2003&amp;pages=520-529&amp;pmid=12560444&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr25-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr26-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">26. <span class="mixed-citation">Larkin J, Chiarion-Sileni V, Gonzalez R, et al. <span class="ref-title">Combined nivolumab and ipilimumab or monotherapy in untreated melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2015;<span class="ref-vol">373</span>(<span class="ref-iss">1</span>):23-34. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698905/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26027431" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Combined+nivolumab+and+ipilimumab+or+monotherapy+in+untreated+melanoma&amp;author=J+Larkin&amp;author=V+Chiarion-Sileni&amp;author=R+Gonzalez&amp;volume=373&amp;issue=1&amp;publication_year=2015&amp;pages=23-34&amp;pmid=26027431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr26-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr27-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">27. <span class="mixed-citation">Hodi FS, O’Day SJ, McDermott DF, et al. <span class="ref-title">Improved survival with ipilimumab in patients with metastatic melanoma</span>. <span class="ref-journal">N Engl J Med</span>. 2010;<span class="ref-vol">363</span>(<span class="ref-iss">8</span>):711-723. <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549297/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20525992" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Improved+survival+with+ipilimumab+in+patients+with+metastatic+melanoma&amp;author=FS+Hodi&amp;author=SJ+O%E2%80%99Day&amp;author=DF+McDermott&amp;volume=363&amp;issue=8&amp;publication_year=2010&amp;pages=711-723&amp;pmid=20525992&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr27-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr28-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">28. <span class="mixed-citation">Luke JJ, Ascierto PA, Carlino MS, et al. <span class="ref-title">KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma</span>. <span class="ref-journal">Future Oncol</span>. 2020;<span class="ref-vol">16</span>(<span class="ref-iss">3</span>):4429-4438. [<a href="https://pubmed.ncbi.nlm.nih.gov/31870188" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Future+Oncol&amp;title=KEYNOTE-716:+Phase+III+study+of+adjuvant+pembrolizumab+versus+placebo+in+resected+high-risk+stage+II+melanoma&amp;author=JJ+Luke&amp;author=PA+Ascierto&amp;author=MS+Carlino&amp;volume=16&amp;issue=3&amp;publication_year=2020&amp;pages=4429-4438&amp;pmid=31870188&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr28-10732748211053567">Ref list</a>]</div><div id="body-link-popper-bibr29-10732748211053567" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 446px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">29. <span class="mixed-citation">Nakamura Y, Namikawa K, Yoshino K, et al. <span class="ref-title">Anti-PD1 checkpoint inhibitor therapy in acral melanoma: A multicenter study of 193 Japanese patients</span>. <span class="ref-journal">Ann Oncol</span>. 2020;<span class="ref-vol">31</span>(<span class="ref-iss">9</span>):1198-1206. [<a href="https://pubmed.ncbi.nlm.nih.gov/32522691" ref="reftype=pubmed&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Anti-PD1+checkpoint+inhibitor+therapy+in+acral+melanoma:+A+multicenter+study+of+193+Japanese+patients&amp;author=Y+Nakamura&amp;author=K+Namikawa&amp;author=K+Yoshino&amp;volume=31&amp;issue=9&amp;publication_year=2020&amp;pages=1198-1206&amp;pmid=32522691&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8581784&amp;issue-id=383838&amp;journal-id=3344&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#bibr29-10732748211053567">Ref list</a>]</div></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/pdf/10.1177_10732748211053567.pdf" class="int-view">PDF (762K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp" aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open" data-all-citations-url="/pmc/resources/citations/8581784/" data-citation-style="nlm" data-download-format-link="/pmc/resources/citations/8581784/export/">
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/overlay-block.css">
<div class="collections-button-container" data-article-id="8581784" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_button" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F%23open-collections-dialog" data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay collections-dialog-overlay" role="dialog">
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true" role="document">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form" class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/pmc/list-existing-collections/" data-add-to-existing-collection-url="/pmc/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="aD759maqipFBjZvd8ORziZ4z6iiwRkGIhG02PkwkvUFWHh8miJUove1z8U2VEg72">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio" id="collections-action-dialog-new-aside " class="collections-new" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio" id="collections-action-dialog-existing-aside " class="collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="collections-action-add-to-new" pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing" class="action-panel-selector collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($(&#39;.collections-action-add-to-existing&#39;).val() === &#39;Favorites&#39;) ? &#39;Favorites&#39; : &#39;non_favorites_collection&#39;">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore="" data-ga-category="collections_button" data-ga-action="click" data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel" aria-label="Close &#39;Add to Collections&#39; panel" ref="linksrc=close_collections_panel" aria-controls="collections-action-panel" aria-expanded="false" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F&amp;text=Acral%20Lentiginous%20Melanoma%3A%20A%20United%20States%20Multi-Center%20Substage%20Survival%20Analysis" alt="Share on Twitter" aria-expanded="false" aria-haspopup="true"><i class="fa fa-twitter fa-stack-1x">&nbsp;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8581784%2F" alt="Share on Facebook" aria-expanded="false" aria-haspopup="true"><i class="fa fa-facebook fa-stack-1x">&nbsp;</i></a></li>
                <li>
                    <div class="share-permalink dropdown-block">
                        <button class="trigger" alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg">
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container">
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="similar-articles-accordion-aside" aria-expanded="false" data-action-open="open_similar_articles" data-action-close="close_similar_articles">
                        Similar articles
                    </button>
                    <div data-source-url="/pmc/resources/similar-article-links/34752172/" class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="cited-by-accordion-aside" aria-expanded="false" data-action-open="open_cited_by" data-action-close="close_cited_by">
                        Cited by other articles
                    </button>
                    <div data-source-url="/pmc/resources/cited-by-links/34752172/" class="usa-accordion-content pmc-sidebar__resources--citations" id="cited-by-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/pmc/articles/PMC8581784/" class="usa-accordion-button" aria-controls="links-accordion-aside" aria-expanded="false" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link">
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8581784/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay citation-dialog-overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog" role="document">
    <button class="close-overlay" tabindex="1" data-pinger-ignore="true">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button class="copy-button dialog-focus" data-ga-category="save_share" data-ga-action="cite" data-ga-label="copy" tabindex="2">
      Copy
    </button>

      <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784/#" class="export-button" data-ga-category="save_share" data-ga-action="cite" data-ga-label="download" title="Download a file for external citation management software" tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4">
    
      <option data-style-url-name="ama" value="AMA">
        AMA
      </option>
    
      <option data-style-url-name="apa" value="APA">
        APA
      </option>
    
      <option data-style-url-name="mla" value="MLA">
        MLA
      </option>
    
      <option data-style-url-name="nlm" value="NLM" selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
<div class="dots-loading-indicator citation-loading-indicator">
        <div class="dot dot-1"></div>
        <div class="dot dot-2"></div>
        <div class="dot dot-3"></div>
      </div></div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer" role="button" aria-expanded="false" aria-haspopup="true"><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank" role="button" aria-expanded="false" aria-haspopup="true">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer" role="button" aria-expanded="false" aria-haspopup="true"><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer" role="button" aria-expanded="false" aria-haspopup="true">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/?pagename=pmc-frontend%3Apmc%3Aarticle%3A%2Farticles%2FPMC8581784%2F" data-pinger-pagename-param="true">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="https://www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.0f72d6a64937.js"></script>
  
  
    <script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/jquery-3.5.0.min.js" integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ=" crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.a212a9fcf845.js"></script>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.7999321d1aac.js"></script>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.7ca436b2ea51.js"></script>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.f8422046fbe0.js"></script>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.ff40c7d85ff8.js"></script>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/base.038d36e4e31104b40a19.js"></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/jig.nojquery.min.js">//</script><script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/common.min.js">//</script><script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/NcbiTagServer.min.js">//</script><script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/crb.min.js">//</script><script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/jactions.min.js">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.340a3b9cce7f.js"></script><div class="fake-body-scroll"></div>
<script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/article.b7dd20e527283dd68f45.js"></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8581784/', citeCookieName: 'pmc-cf'});
    </script><div class="fake-body-scroll"></div><div class="fake-body-scroll"></div>


  
  
  <script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/pinger.js"> </script><div id="ZN_dikYWqsjiUWN0Q5"></div>


  
      
  



<div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><script type="text/javascript" src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/saved_resource"></script><script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/CoreModule.js" defer=""></script><script src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/FeedbackButtonModule.js" defer=""></script><style type="text/css">.QSIFeedbackButton div,.QSIFeedbackButton dl,.QSIFeedbackButton dt,.QSIFeedbackButton dd,.QSIFeedbackButton ul,.QSIFeedbackButton ol,.QSIFeedbackButton li,.QSIFeedbackButton h1,.QSIFeedbackButton h2,.QSIFeedbackButton h3,.QSIFeedbackButton h4,.QSIFeedbackButton h5,.QSIFeedbackButton h6,.QSIFeedbackButton span,.QSIFeedbackButton pre,.QSIFeedbackButton form,.QSIFeedbackButton fieldset,.QSIFeedbackButton textarea,.QSIFeedbackButton p,.QSIFeedbackButton blockquote,.QSIFeedbackButton tr,.QSIFeedbackButton th,.QSIFeedbackButton td{ margin: 0; padding: 0;background-color: transparent; border: 0; font-size: 12px; line-height: normal; vertical-align:baseline; box-shadow: none; }.QSIFeedbackButton img{ height: auto; width: auto; margin: 0; padding: 0 }.QSIFeedbackButton ul,.QSIFeedbackButton ol{ margin: 12px 0; padding-left: 40px; }.QSIFeedbackButton ul li{ list-style-type: disc; }.QSIFeedbackButton ol li{ list-style-type: decimal; }.QSIFeedbackButton .scrollable{ -webkit-overflow-scrolling: touch; }.QSIFeedbackButton table{ border-collapse: collapse; border-spacing: 0; }.QSIFeedbackButton table td{ padding: 2px; }.QSIFeedbackButton iframe{ max-height: none; }.QSIFeedbackButton *{ box-sizing: content-box; }</style><div class="QSIFeedbackButton" style="position: fixed; visibility: hidden; inset: 0px; display: flex; flex-direction: column; justify-content: flex-end; align-items: flex-start; margin: 0px; padding: 0px; z-index: 2000000000;"><button role="button" aria-label="Tell us what you think!" id="QSIFeedbackButton-btn" aria-expanded="false" aria-controls="QSIFeedbackButton-target-container" style="position: fixed; visibility: visible; cursor: pointer; border: none; background-color: transparent; padding: 0px; margin: 0px; bottom: 137px; right: -1px; width: 52px; transition: all 0.5s ease 0s;"><img src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/Feedback+Button_vt.png" alt="Tell us what you think!" style="max-width: 110px; max-height: 110px; display: block;"></button></div><div id="QSIFeedbackButton-target-container" class="QSIFeedbackButton" role="dialog" aria-hidden="true" aria-labelledby="QSIFeedbackButton-btn" style="position: fixed; overflow: hidden; color: rgb(0, 0, 0); background-color: rgb(237, 237, 237); border-top: 2px solid rgb(166, 166, 166); border-right: none; border-bottom: 2px solid rgb(166, 166, 166); border-left: 2px solid rgb(166, 166, 166); border-image: initial; box-sizing: border-box; transition: all 0.5s ease 0s; margin: 0px; padding: 0px; z-index: 2000000001; height: 50%; border-radius: 2px 0px 0px 2px; max-width: 400px; width: 100vw; left: 100%; bottom: 0px;"><div id="QSIFeedbackButton-close-btn-container" style="background-color: transparent; padding-bottom: 10px; right: 10px; top: 10px; position: absolute; display: flex; justify-content: flex-end;"><button role="button" id="QSIFeedbackButton-close-btn" tabindex="-1" style="cursor: pointer; border: 0px; padding: 0px; background-color: transparent; z-index: 2000000001; margin: 0px;"><img src="./Acral Lentiginous Melanoma_ A United States Multi-Center Substage Survival Analysis - PMC_files/wr-dialog-close-btn-black.png" alt="Close" style="height: 17px; width: 17px;"></button><div id="QSIFeedbackButton-close-btn-background" style="position: absolute; width: 28px; height: 28px; border-radius: 14px; top: -5px; right: -5px; background-color: rgb(255, 255, 255); opacity: 0.5;"></div></div></div></body></html>